<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="systematic-review" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Neurol.</journal-id>
<journal-title>Frontiers in Neurology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Neurol.</abbrev-journal-title>
<issn pub-type="epub">1664-2295</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fneur.2023.1257781</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neurology</subject>
<subj-group>
<subject>Systematic Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Gender discrepancies and differences in motor and non-motor symptoms, cognition, and psychological outcomes in the treatment of Parkinson&#x2019;s disease with subthalamic deep brain stimulation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Hendriks</surname> <given-names>Martijn</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2563757/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author"><name><surname>Vinke</surname> <given-names>Ruben Saman</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Georgiev</surname> <given-names>Dejan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/148556/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Neurology, University Medical Centre Ljubljana</institution>, <addr-line>Ljubljana</addr-line>, <country>Slovenia</country></aff>
<aff id="aff2"><sup>2</sup><institution>Donders Institute for Brain, Cognition and Behaviour, Department of Neurosurgery, Radboud University Medical Centre</institution>, <addr-line>Nijmegen</addr-line>, <country>Netherlands</country></aff>
<aff id="aff3"><sup>3</sup><institution>Laboratory for Artificial Intelligence, Faculty of Computer and Information Science, University of Ljubljana</institution>, <addr-line>Ljubljana</addr-line>, <country>Slovenia</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0001">
<p>Edited by: Manuela Altieri, University of Campania Luigi Vanvitelli, Italy</p>
</fn>
<fn fn-type="edited-by" id="fn0002">
<p>Reviewed by: Drew Kern, University of Colorado Hospital, United States; Jing He, Chinese Academy of Medical Sciences, China</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: Dejan Georgiev, <email>dejan.georgiev@kclj.si</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>08</day>
<month>01</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1257781</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>07</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>12</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2024 Hendriks, Vinke and Georgiev.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Hendriks, Vinke and Georgiev</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Available data suggest that there may be gender differences in the effect of STN-DBS in the treatment of Parkinson&#x2019;s disease (PD). The aim of this study was to review data on gender discrepancies and gender differences in clinical outcomes in PD patients treated with deep brain stimulation of the subthalamic nucleus (STN-DBS). Included were original studies that specifically examined gender discrepancies or gender differences in PD patients with STN-DBS. Men receive more DBS than women, for various indications. The decision-making process for DBS in women compared to men is more influenced by personal preferences and external factors. Motor symptoms improve in both genders, but bradykinesia improves more in men. The postoperative reduction of the levodopa equivalent daily dose seems to be more pronounced in men. Men show more cognitive deterioration and less improvement than women after STN-DBS. Women show more depressive symptoms before surgery, but they improve similarly to men. Men show more improvement in impulsivity and less decrease in impulsive behaviour symptoms than women. Anxiety and personality traits remain unchanged in both genders. Voice quality improves more in men and deteriorates less often than in women. Men gain fat-free mass and fat mass, but women only gain fat mass. Regarding sexual function the evidence is inconsistent. More urinary symptoms improve in women than in men. Pain and restless leg syndrome seems to improve more in men. Regarding quality of life, the evidence seems to be inconsistent, and activities of daily living seems to improve in both genders. Better prospective controlled studies, focusing directly on gender differences in PD patients treated with STN-DBS, are needed to better explain gender differences in STN-DBS for PD.</p>
</abstract>
<kwd-group>
<kwd>Parkinson&#x2019;s disease</kwd>
<kwd>deep brain stimulation</kwd>
<kwd>gender differences</kwd>
<kwd>gender discrepancies</kwd>
<kwd>cognition and psychological outcomes</kwd>
<kwd>motor symptoms</kwd>
<kwd>non-motor symptoms</kwd>
</kwd-group>
<counts>
<fig-count count="1"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="86"/>
<page-count count="13"/>
<word-count count="9401"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Movement Disorders</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec1">
<title>Introduction</title>
<p>Parkinson&#x2019;s disease (PD) is a progressive neurodegenerative disease that affects many areas of life. Early cardinal motor symptoms of PD include bradykinesia, rigidity and rest tremor (<xref ref-type="bibr" rid="ref1">1</xref>). As the disease progresses, other motor symptoms develop, including gait disturbances and postural instability (<xref ref-type="bibr" rid="ref2">2</xref>). In addition, non-motor symptoms are also common and can greatly affect quality of life and include, for example, autonomic dysfunction, sleep disturbances, cognitive and psychological changes (<xref ref-type="bibr" rid="ref3">3</xref>). Over the last three decades, deep brain stimulation of the subthalamic nucleus (STN-DBS) has been shown to be an effective treatment for advanced PD (<xref ref-type="bibr" rid="ref4">4</xref>). The treatment involves the surgical implantation of electrodes into the STN, from where electrical impulses are sent to modulate abnormal neuronal activity. The results of multiple studies indicate a long-term improvement in most motor and non-motor symptoms of the disease (<xref ref-type="bibr" rid="ref5 ref6 ref7">5&#x2013;7</xref>). Emerging evidence indicates that there are important gender differences in the clinical presentation and development of PD (<xref ref-type="bibr" rid="ref8 ref9 ref10">8&#x2013;10</xref>). To illustrate, PD is more prevalent in men (<xref ref-type="bibr" rid="ref11">11</xref>, <xref ref-type="bibr" rid="ref12">12</xref>), in whom the disease seems to start at a younger age (<xref ref-type="bibr" rid="ref9">9</xref>). On the other hand, tremor-dominant PD is more common in women than in men and women suffer more often from dyskinesias. Similarly, men seem to perform worse on tests of cognitive abilities, but women seem to be more susceptible to depression and anxiety (<xref ref-type="bibr" rid="ref13">13</xref>). The aim of this review is to investigate gender discrepancies (gender distribution and patient perspective towards STN-DBS) and possible gender differences in clinical outcomes (motor and non-motor symptoms, including cognition and psychological characteristics) in PD patients treated with STN-DBS.</p>
</sec>
<sec sec-type="materials|methods" id="sec2">
<title>Materials and methods</title>
<p>A systematic search strategy on Pubmed and Web of Science was conducted in May 2023 and included the following search terms and all their synonyms (for the exact search strings please see <xref ref-type="supplementary-material" rid="SM1">Supplementary material</xref>): Parkinson&#x2019;s disease, subthalamic deep brain stimulation and gender. The inclusion criteria consisted of primary articles written in English that examined gender differences in PD patients treated with STN-DBS, with outcomes related to gender discrepancies and gender differences in clinical outcomes, including cognitive and psychological characteristics of patients, and other non-motor and motor symptoms. All articles had to be approved by two researchers (MH and DG). Using this systematic search strategy, 605 individual articles were identified. According to the above criteria, 41 individual articles were finally included (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p>
<fig position="float" id="fig1"><label>Figure 1</label>
<caption>
<p>Flowchart of the screening and selection process for articles included in this review.</p>
</caption>
<graphic xlink:href="fneur-14-1257781-g001.tif"/>
</fig>
</sec>
<sec sec-type="results" id="sec3">
<title>Results</title>
<p>The results of the analysis are presented in <xref ref-type="table" rid="tab1">Table 1</xref> and will be discussed in the following sections.</p>
<table-wrap position="float" id="tab1"><label>Table 1</label>
<caption>
<p>Studies included in the review.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">First author, year</th>
<th align="center" valign="top">M: N (%)</th>
<th align="center" valign="top">F: N (%)</th>
<th align="left" valign="top">Study type</th>
<th align="center" valign="top">Main objective</th>
<th align="center" valign="top">O: D</th>
<th align="center" valign="top">O: M</th>
<th align="center" valign="top">O: C/P</th>
<th align="center" valign="top">O: NM</th>
<th align="center" valign="top">O: Oth</th>
<th align="left" valign="top">Summary of main gender-related results</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="bottom">Accolla et al. (2007)</td>
<td align="center" valign="bottom">22 (58)</td>
<td align="center" valign="bottom">16 (42)</td>
<td align="left" valign="bottom">Prospective study</td>
<td align="left" valign="bottom">To investigate preoperative and postoperative gender differences in PD patients treated with STN-DBS</td>
<td/>
<td align="center" valign="bottom">X</td>
<td/>
<td/>
<td align="center" valign="bottom">X</td>
<td align="left" valign="bottom">Men had more improvement in bradykinesia than women</td>
</tr>
<tr>
<td align="left" valign="bottom">Andreasi et al. (2022)</td>
<td align="center" valign="bottom">71 (66)</td>
<td align="center" valign="bottom">36 (33)</td>
<td align="left" valign="bottom">Retrospective study</td>
<td align="left" valign="bottom">To investigate long term motor effects and gender differences in outcomes in PD patients treated with STN-DBS</td>
<td/>
<td align="center" valign="bottom">X</td>
<td/>
<td/>
<td align="center" valign="bottom">X</td>
<td align="left" valign="bottom">The effect of DBS on LEDD reduction was modulated by sex</td>
</tr>
<tr>
<td align="left" valign="bottom">Bannier et al. (2009)</td>
<td align="center" valign="bottom">15 (68)</td>
<td align="center" valign="bottom">7 (32)</td>
<td align="left" valign="bottom">Prospective study</td>
<td align="left" valign="bottom">To investigate weight gain in PD patients treated with STN-DBS</td>
<td/>
<td/>
<td/>
<td align="center" valign="bottom">X</td>
<td/>
<td align="left" valign="bottom">Men gained weight in fat free mass and fat mass, while women only gained weight in fat mass</td>
</tr>
<tr>
<td align="left" valign="bottom">Bove et al. (2020)</td>
<td align="center" valign="bottom">110 (63)</td>
<td align="center" valign="bottom">65 (37)</td>
<td align="left" valign="bottom">Retrospective study</td>
<td align="left" valign="bottom">To investigate dementia after STN-DBS in PD patients</td>
<td/>
<td/>
<td align="center" valign="bottom">X</td>
<td/>
<td/>
<td align="left" valign="bottom">Male sex was a predictive factor for dementia after STN-DBS</td>
</tr>
<tr>
<td align="left" valign="bottom">Castelli et al. (2004)</td>
<td align="center" valign="bottom">21 (68)</td>
<td align="center" valign="bottom">10 (32)</td>
<td align="left" valign="bottom">Prospective study</td>
<td align="left" valign="bottom">To investigate the effect of STN-DBS on sexual well-being in PD patients</td>
<td/>
<td/>
<td align="center" valign="bottom">X</td>
<td align="center" valign="bottom">X</td>
<td/>
<td align="left" valign="bottom">Only men improved in satisfaction</td>
</tr>
<tr>
<td align="left" valign="bottom">Chan et al. (2017)</td>
<td align="center" valign="bottom">PD with DBS (targets not specified): 12,366 (68). PD control/overall: 1,276,400 (53)</td>
<td align="center" valign="bottom">PD with DBS (targets not specified): 5,946 (32). PD control/overall: 1,131,902 (47)</td>
<td align="left" valign="bottom">Retrospective study</td>
<td align="left" valign="bottom">To investigate predictive factors for DBS use in PD patients in the United States</td>
<td align="center" valign="bottom">X</td>
<td/>
<td/>
<td/>
<td/>
<td align="left" valign="bottom">Male sex was a predictive factor for receiving DBS in PD population</td>
</tr>
<tr>
<td align="left" valign="bottom">Chandran et al. 2014</td>
<td align="center" valign="bottom">32 (63)</td>
<td align="center" valign="bottom">19 (37)</td>
<td align="left" valign="bottom">Prospective study</td>
<td align="left" valign="bottom">To investigate gender differences in preoperative characteristics and post-operative outcomes in PD patients treated with STN-DBS</td>
<td/>
<td align="center" valign="bottom">X</td>
<td align="center" valign="bottom">X</td>
<td align="center" valign="bottom">X</td>
<td align="center" valign="bottom">X</td>
<td align="left" valign="bottom">More reduction in LEDD in men than women</td>
</tr>
<tr>
<td align="left" valign="bottom">Chiou. (2015)</td>
<td align="center" valign="bottom">48 (67)</td>
<td align="center" valign="bottom">24 (33)</td>
<td align="left" valign="bottom">Prospective study</td>
<td align="left" valign="bottom">To investigate gender-related predictive factors of outcomes in PD patients treated with STN-DBS</td>
<td/>
<td align="center" valign="bottom">X</td>
<td/>
<td align="center" valign="bottom">X</td>
<td align="center" valign="bottom">X</td>
<td align="left" valign="bottom">Men with lower LEDD, worse motor scores, worse tremor or better medication response for tremor and rigidity showed better motor improvement. Women with preoperatively worse motor scores, better ADL or better medication response for akinesia showed better motor improvement</td>
</tr>
<tr>
<td align="left" valign="bottom">Dalrymple et al. (2019)</td>
<td align="center" valign="bottom">95 (69) (STN, GPi, Vim)</td>
<td align="center" valign="bottom">42 (31) (STN, GPi, Vim)</td>
<td align="left" valign="bottom">Retrospective study</td>
<td align="left" valign="bottom">To investigate differences of PD patients characteristics based on the primary indication for DBS</td>
<td align="center" valign="bottom">X</td>
<td/>
<td/>
<td/>
<td/>
<td align="left" valign="bottom">Men were more likely to undergo DBS for medication refractory tremor than women</td>
</tr>
<tr>
<td align="left" valign="bottom">Deshpande et al. (2022)</td>
<td align="center" valign="bottom">DBS for PD (STN, GPi): 35 (66). DBS for ET (Vim): 27 (52)</td>
<td align="center" valign="bottom">DBS for PD (STN, GPi):18 (34). DBS for ET (Vim): 25 (48)</td>
<td align="left" valign="bottom">Retrospective study</td>
<td align="left" valign="bottom">To investigate a potential gender disparity in the interval from a movement disorder diagnosis to DBS usage in PD patients and ET patients</td>
<td align="center" valign="bottom">X</td>
<td/>
<td/>
<td/>
<td align="center" valign="bottom">X</td>
<td align="left" valign="bottom">At surgery consultation, females had more reduction in UPDRS motor scores with medication than males</td>
</tr>
<tr>
<td align="left" valign="bottom">Dietrich et al. (2020)</td>
<td align="center" valign="bottom">34 (74)</td>
<td align="center" valign="bottom">12 (26)</td>
<td align="left" valign="bottom">Prospective study</td>
<td align="left" valign="bottom">To evaluate effect of STN-DBS on mood and personality with a focus of sex disparities in PD patients</td>
<td/>
<td align="center" valign="bottom">X</td>
<td align="center" valign="bottom">X</td>
<td/>
<td align="center" valign="bottom">X</td>
<td align="left" valign="bottom">Women showed more improvement in QoL</td>
</tr>
<tr>
<td align="left" valign="bottom">Erdogan et al. (2020)</td>
<td align="center" valign="bottom">20 (51)</td>
<td align="center" valign="bottom">19 (49)</td>
<td align="left" valign="bottom">Retrospective study</td>
<td align="left" valign="bottom">To investigate predictive factors for favourable outcome in PD patients treated with STN-DBS</td>
<td/>
<td align="center" valign="bottom">X</td>
<td/>
<td/>
<td/>
<td align="left" valign="bottom">Sex was not a predictive factor for the motor outcome after STN-DBS</td>
</tr>
<tr>
<td align="left" valign="bottom">Foubert-Samier et al. (2012)</td>
<td align="center" valign="bottom">31 (66)</td>
<td align="center" valign="bottom">16 (34)</td>
<td align="left" valign="bottom">Cross-sectional study</td>
<td align="left" valign="bottom">To investigate weight changes after STN-DBS in PD patients</td>
<td/>
<td/>
<td/>
<td align="center" valign="bottom">X</td>
<td/>
<td align="left" valign="bottom">Women increased more in BMI than men</td>
</tr>
<tr>
<td align="left" valign="bottom">Hamberg et al. (2014)</td>
<td align="center" valign="bottom">(Targets not specified): 31 (74)</td>
<td align="center" valign="bottom">(Targets not specified): 11 (26)</td>
<td align="left" valign="bottom">Qualitative cross-sectional study</td>
<td align="left" valign="bottom">To investigate the decision-making process prior DBS from PD patient&#x2019;s perspective and explore gender patterns</td>
<td align="center" valign="bottom">X</td>
<td/>
<td/>
<td/>
<td/>
<td align="left" valign="bottom">During the decision-making process prior DBS, women were more represented in the &#x201C;hesitating and waiting&#x201D; category than men</td>
</tr>
<tr>
<td align="left" valign="bottom">Hariz et al. (2013)</td>
<td align="center" valign="bottom">31 (63)</td>
<td align="center" valign="bottom">18 (37)</td>
<td align="left" valign="bottom">Prospective study</td>
<td align="left" valign="bottom">To investigate possible gender difference in health quality of life in PD patients treated with STN-DBS</td>
<td/>
<td align="center" valign="bottom">X</td>
<td/>
<td/>
<td align="center" valign="bottom">X</td>
<td align="left" valign="bottom">Women showed improvement in QoL and in more subdomains</td>
</tr>
<tr>
<td align="left" valign="bottom">Hu et al. (2022)</td>
<td align="center" valign="bottom">65 (55)</td>
<td align="center" valign="bottom">53 (45)</td>
<td align="left" valign="bottom">Retrospective study</td>
<td align="left" valign="bottom">To explore the effect and predictive factors of STN-DBS on depression in PD patients</td>
<td/>
<td/>
<td align="center" valign="bottom">X</td>
<td/>
<td/>
<td align="left" valign="bottom">Female sex was a predictive factor for the improvement of depression</td>
</tr>
<tr>
<td align="left" valign="bottom">Jost et al. (2022)</td>
<td align="center" valign="bottom">Cross-sectional cohort (STN, GPi, Vim):<break/>214 (68). Longitudinal cohort (STN):<break/>121 (64). PD-controls: 58 (50)</td>
<td align="center" valign="bottom">Cross-sectional cohort (STN, GPi, Vim):<break/>102 (32). Longitudinal cohort (STN):<break/>68 (36). PD-controls: 58 (50)</td>
<td align="left" valign="bottom">Cross-sectional and prospective controlled study</td>
<td align="left" valign="bottom">To investigate gender proportions and preoperative and postoperative gender differences in PD patients treated with STN-DBS</td>
<td align="center" valign="bottom">X</td>
<td align="center" valign="bottom">X</td>
<td/>
<td align="center" valign="bottom">X</td>
<td align="center" valign="bottom">X</td>
<td align="left" valign="bottom">Men improved more in bradykinesia than women and only men improved in emotional well-being, mood and apathy, perceptual problems, and hallucinations, while only in women improved in attention and memory</td>
</tr>
<tr>
<td align="left" valign="bottom">Khazen et al.(2020)</td>
<td align="center" valign="bottom">14 (70)</td>
<td align="center" valign="bottom">6 (30)</td>
<td align="left" valign="bottom">Prospective study</td>
<td align="left" valign="bottom">To investigate gender differences in pain in PD patients treated with STN-DBS</td>
<td/>
<td/>
<td/>
<td align="center" valign="bottom">X</td>
<td align="center" valign="bottom">X</td>
<td align="left" valign="bottom">Only men improved significantly on pain scales, of which men improved more than females in musculoskeletal and chronic pain</td>
</tr>
<tr>
<td align="left" valign="bottom">Kim et al.(2019)</td>
<td align="center" valign="bottom">48 (48)</td>
<td align="center" valign="bottom">52 (52)</td>
<td align="left" valign="bottom">Prospective study</td>
<td align="left" valign="bottom">To investigate sex differences in short-term and long-term effects of STN-DBS on clinical outcomes in PD patients</td>
<td/>
<td align="center" valign="bottom">X</td>
<td align="center" valign="bottom">X</td>
<td/>
<td align="center" valign="bottom">X</td>
<td align="left" valign="bottom">Physical HRQoL improved in more domains in men than in women, which was more prominent at 5&#x2009;years than 1&#x2009;year follow up</td>
</tr>
<tr>
<td align="left" valign="bottom">Kim et al.(2019)</td>
<td align="center" valign="bottom">87 (44)</td>
<td align="center" valign="bottom">109 (56)</td>
<td align="left" valign="bottom">Retrospective study</td>
<td align="left" valign="bottom">To investigate the change in functional status after STN-DBS in PD patients</td>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="bottom">X</td>
<td align="left" valign="bottom">Female sex was predictor for functional dependence after STN-DBS</td>
</tr>
<tr>
<td align="left" valign="bottom">K&#x00FC;bler et al.(2023)</td>
<td align="center" valign="bottom">147 (72)</td>
<td align="center" valign="bottom">56 (28)</td>
<td align="left" valign="bottom">Retrospective study</td>
<td align="left" valign="bottom">To evaluate gender-specific post-surgical outcomes in PD patients treated with STN-DBS</td>
<td/>
<td align="center" valign="bottom">X</td>
<td align="center" valign="bottom">X</td>
<td align="center" valign="bottom">X</td>
<td align="center" valign="bottom">X</td>
<td align="left" valign="bottom">Only women improved in cognition and only men in depressive symptoms and impulsivity</td>
</tr>
<tr>
<td align="left" valign="bottom">Lee et al.(2011)</td>
<td align="center" valign="bottom">PD STN-DBS: 30 (70). PD-controls/without DBS: 17 (81)</td>
<td align="center" valign="bottom">PD STN-DBS 13 (30). PD-controls/without DBS: 4 (19)</td>
<td align="left" valign="bottom">Retrospective case-control study</td>
<td align="left" valign="bottom">To compare weight changes in STN-DBS PD patients with matched PD patients without STN-DBS</td>
<td/>
<td/>
<td/>
<td align="center" valign="bottom">X</td>
<td/>
<td align="left" valign="bottom">Both men and women gained weight</td>
</tr>
<tr>
<td align="left" valign="bottom">Lee et al.(2008)</td>
<td align="center" valign="bottom">STN-DBS: 11 (58). PD-controls/without DBS: 4 (40). Healthy controls: 5 (45)</td>
<td align="center" valign="bottom">STN-DBS: 8 (42). PD-controls/without DBS: 6 (60). Healthy controls: 6 (55)</td>
<td align="left" valign="top">Prospective controlled study</td>
<td align="left" valign="top">To investigate the effect of STN-DBS on vocal characteristics in PD patients</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">X</td>
<td/>
<td align="left" valign="top">Only men showed better voice characteristics compared to PD controls</td>
</tr>
<tr>
<td align="left" valign="top">Merola et al.(2017)</td>
<td align="center" valign="top">86 (57)</td>
<td align="center" valign="top">64 (43)</td>
<td align="left" valign="top">Retrospective study</td>
<td align="left" valign="top">To investigate impulse control behaviours after STN-DBS</td>
<td/>
<td/>
<td align="center" valign="top">X</td>
<td/>
<td/>
<td align="left" valign="top">More women developed new-onset ICB than men after STN-DBS</td>
</tr>
<tr>
<td align="left" valign="top">Montaurier et al.(2007)</td>
<td align="center" valign="top">PD STN-DBS: 17 (71). Healthy controls: 17 (71)</td>
<td align="center" valign="top">PD STN-DBS: 7 (29). Healthy controls: 7 (29)</td>
<td align="left" valign="top">Prospective controlled study</td>
<td align="left" valign="top">To investigate mechanisms of weight gain after STN-DBS in PD patients</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">X</td>
<td/>
<td align="left" valign="top">Women increased in fat mass, while men increase in fat free mass and fat mass</td>
</tr>
<tr>
<td align="left" valign="top">Pedro et al.(2020)</td>
<td align="center" valign="top">PD STN-DBS: 12 (57). PD-controls/without DBS: 9 (47)</td>
<td align="center" valign="top">PD STN-DBS: 9 (43). PD-controls/without DBS: 10 (53)</td>
<td align="left" valign="top">Retrospective study</td>
<td align="left" valign="top">To investigate the effect of STN-DBS on sexual function in PD patients</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">X</td>
<td/>
<td align="left" valign="top">No effect of STN-DBS on sexual function for both genders</td>
</tr>
<tr>
<td align="left" valign="top">Roediger et al.(2019)</td>
<td align="center" valign="top">NR</td>
<td align="center" valign="top">NR</td>
<td align="left" valign="top">Retrospective study</td>
<td align="left" valign="top">To investigate the effect of STN-DBS on postural abnormalities in PD patients</td>
<td/>
<td align="center" valign="top">X</td>
<td/>
<td/>
<td/>
<td align="left" valign="top">Male gender was a predictive factor for posture improvement after STN-DBS</td>
</tr>
<tr>
<td align="left" valign="top">Rogers et al.(2011)</td>
<td align="center" valign="top">10 (45)</td>
<td align="center" valign="top">12 (55)</td>
<td align="left" valign="top">Cross-over study</td>
<td align="left" valign="top">To investigate the effect of STN-DBS on loss chasing behaviour in PD patients</td>
<td/>
<td/>
<td align="center" valign="top">X</td>
<td/>
<td/>
<td align="left" valign="top">The value of losses chased increased more in women than in men with STN-DBS</td>
</tr>
<tr>
<td align="left" valign="top">Romito et al.(2010)</td>
<td align="center" valign="top">11 (55)</td>
<td align="center" valign="top">9 (45)</td>
<td align="left" valign="top">Prospective study</td>
<td align="left" valign="top">To investigate long-term gender differences in clinical outcomes and disease progression in PD patients treated with STN-DBS</td>
<td/>
<td align="center" valign="top">X</td>
<td/>
<td/>
<td align="center" valign="top">X</td>
<td align="left" valign="top">At 1&#x2009;year follow-up, men showed more motor improvement than women</td>
</tr>
<tr>
<td align="left" valign="top">Sarac et al.(2020)</td>
<td align="center" valign="top">8 (67)</td>
<td align="center" valign="top">4 (33)</td>
<td align="left" valign="top">Prospective study</td>
<td align="left" valign="top">To investigate the effect of STN-DBS on voice characteristics in PD patients</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">X</td>
<td/>
<td align="left" valign="top">Only in women some indication for worsening voice quality, but not statistically significant</td>
</tr>
<tr>
<td align="left" valign="top">Shpiner et al.(2019)</td>
<td align="center" valign="top">DBS-referral: 157 (76). DBS-surgery (targets not specified): 77 (77)</td>
<td align="center" valign="top">DBS-referral: 50 (24). DBS-surgery (targets not specified): 23 (23)</td>
<td align="left" valign="top">Retrospective study</td>
<td align="left" valign="top">To investigate gender disparities in PD patients undergoing DBS</td>
<td align="center" valign="top">X</td>
<td align="center" valign="top">X</td>
<td/>
<td/>
<td align="center" valign="top">X</td>
<td align="left" valign="top">Reasons not to receive DBS: women more likely due to their personal preference, while men were more prone to being lost to follow-up before surgery</td>
</tr>
<tr>
<td align="left" valign="top">Sperens et al.(2017)</td>
<td align="center" valign="top">PD without DBS: 13 (57)</td>
<td align="center" valign="top">PD without DBS: 10 (43)</td>
<td align="left" valign="top">Qualitative cross-sectional study</td>
<td align="left" valign="top">To investigate knowledge and reasoning about DBS in PD patients</td>
<td align="center" valign="top">X</td>
<td/>
<td/>
<td/>
<td/>
<td align="left" valign="top">Men and women showed no difference between their reasoning about DBS</td>
</tr>
<tr>
<td align="left" valign="top">Su et al.(2017)</td>
<td align="center" valign="top">11 (48)</td>
<td align="center" valign="top">12 (52)</td>
<td align="left" valign="top">Retrospective study</td>
<td align="left" valign="top">To investigate predictive factors for the predictive value of levodopa responsiveness and predictive factors for STN-DBS outcomes in PD patients</td>
<td/>
<td align="center" valign="top">X</td>
<td/>
<td/>
<td/>
<td align="left" valign="top">Preoperative levodopa responsiveness was a predictor for motor improvement only in women</td>
</tr>
<tr>
<td align="left" valign="top">Tanaka et al.(2015)</td>
<td align="center" valign="top">PD STN-DBS: 28 (41). PD-controls/without DBS: 15 (38)</td>
<td align="center" valign="top">PD STN-DBS: 40 (59). PD-controls/without DBS: 25 (63)</td>
<td align="left" valign="top">Cross-sectional controlled study</td>
<td align="left" valign="top">To investigate voice characteristics of PD patients treated with STN-DBS</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">X</td>
<td/>
<td align="left" valign="top">Women showed worsening in more voice characteristics after STN-DBS compared to PD controls and improvement in less voice characteristics after switching stimulation off than men</td>
</tr>
<tr>
<td align="left" valign="top">Vinke et al.(2022)</td>
<td align="center" valign="top">Awake STN-DBS: 25 (83). Asleep STN-DBS: 53 (58)</td>
<td align="center" valign="top">Awake STN-DBS: 5 (17). Asleep STN-DBS: 38 (42)</td>
<td align="left" valign="top">Retrospective study</td>
<td align="left" valign="top">To investigate the change of gender distribution from awake DBS surgical procedure with micro-electrode recording and intraoperative testing to an asleep MRI-guided and CT-verified approach for PD patients treated with STN-DBS</td>
<td align="center" valign="top">X</td>
<td/>
<td/>
<td/>
<td/>
<td align="left" valign="top">More women underwent DBS surgery, after changing from awake to asleep surgery</td>
</tr>
<tr>
<td align="left" valign="top">Wattanabe et al.(2022)</td>
<td align="center" valign="top">PD with DBS (targets not specified): 49 (66). PD-controls/overall: 2580 (61)</td>
<td align="center" valign="top">PD with DBS (targets no specified): 25 (34). PD-controls/overall: 1635 (39)</td>
<td align="left" valign="top">Retrospective study</td>
<td align="left" valign="top">To characterize the PD population in Hawai and the use of DBS among AA- and NHPI-patients</td>
<td align="center" valign="top">X</td>
<td/>
<td/>
<td/>
<td/>
<td align="left" valign="top">Only males received DBS in NHPI subgroup</td>
</tr>
<tr>
<td align="left" valign="top">Willis et al.(2014)</td>
<td align="center" valign="top">PD with DBS (targets not specified): 4996 (59). PD control/overall: 331870 (50)</td>
<td align="center" valign="top">PD with DBS (targets not specified): 3424 (41). PD control/overall: 329987 (50)</td>
<td align="left" valign="top">Retrospective study</td>
<td align="left" valign="top">To investigate factors associated with DBS in PD patients</td>
<td align="center" valign="top">X</td>
<td/>
<td/>
<td/>
<td/>
<td align="left" valign="top">Male sex was an independent predictive factor for receiving DBS</td>
</tr>
<tr>
<td align="left" valign="top">Witte et al.(2018)</td>
<td align="center" valign="top">STN-DBS: 44 (70). GPi-DBS: 44 (68)</td>
<td align="center" valign="top">STN-DBS: 19 (30). GPi-DBS: 21 (32)</td>
<td align="left" valign="top">Prospective study</td>
<td align="left" valign="top">To investigate the effect of STN- and GPi-DBS on lower urinary tract symptoms in advanced PD</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">X</td>
<td/>
<td align="left" valign="top">Both men and women improved in urinary incontinence and frequency</td>
</tr>
<tr>
<td align="left" valign="top">Xie et al.(2011)</td>
<td align="center" valign="top">PD STN-DBS: 5 (45). Healthy controls: 4 (40)</td>
<td align="center" valign="top">PD-STN-DBS 6 (55). Healthy controls: 6 (60)</td>
<td align="left" valign="top">Prospective controlled study</td>
<td align="left" valign="top">To investigate the effect of STN-DBS on speech in PD patients</td>
<td/>
<td align="center" valign="top">X</td>
<td/>
<td align="center" valign="top">X</td>
<td/>
<td align="left" valign="top">Only within women several significant differences in vowel &#x201C;i&#x201D; with different medication and stimulation conditions</td>
</tr>
<tr>
<td align="left" valign="top">Yuan et al.(2023)</td>
<td align="center" valign="top">55 (61)</td>
<td align="center" valign="top">35 (39)</td>
<td align="left" valign="top">Retrospective study</td>
<td align="left" valign="top">To investigate sex differences on motor and non-motor symptoms and quality of life in PD patients treated with STN-DBS</td>
<td/>
<td align="center" valign="top">X</td>
<td align="center" valign="top">X</td>
<td align="center" valign="top">X</td>
<td align="center" valign="top">X</td>
<td align="left" valign="top">Only men showed motor improvement in med-on conditions and total QoL and more QoL subdomains and men improved more in RLS symptoms</td>
</tr>
<tr>
<td align="left" valign="top">Zong et al.(2019)</td>
<td align="center" valign="top">PD with DBS (targets not specified): 160 (73). PD-controls/without DBS: 148 (76)</td>
<td align="center" valign="top">PD with DBS (targets not specified): 60 (27). PD-controls/without DBS: 48 (24)</td>
<td align="left" valign="top">Prospective study</td>
<td align="left" valign="top">To investigate effect of DBS on urinary dysfunctions in PD patients</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">X</td>
<td/>
<td align="left" valign="top">Women improved in more urinary outcomes than men</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>The number of male (M) and female (F) patients, their proportion, study time, main objective of the study, and different outcomes (O): gender discrepancies (O:D), motor outcomes (O:M), cognitive and psychological outcomes (O:C/P), other non-motor outcomes (O:NM), and other outcomes (O:Oth) were extracted and analysed. Summary of the main gender-related findings is also given in the table. AA, Asian Americans; ADL, activities of daily living; BMI, body mass index; ET, essential tremor; GPi, Globus Pallidus internus; (H)QoL, health-related, quality of life; LEDD, levodopa equivalent daily dose; NHPI, Native Hawaiians, and Other Pacific Islanders; NR, not reported; PD, Parkinson&#x2019;s disease; RLS, restless legs syndrome; STN-DBS, Subthalamic nucleus deep brain stimulation; Vim, ventral intermediate nucleus; UPDRS, unified Parkinson&#x2019;s disease rating scale. The outcomes addressed in separate papers are marked with &#x201C;X.&#x201D;</p>
</table-wrap-foot>
</table-wrap>
<sec id="sec4">
<title>Gender discrepancies in PD patients treated with STN-DBS</title>
<sec id="sec5">
<title>Gender distribution</title>
<p>Two studies showed that male gender was an independent predictive factor for treatment with DBS in PD patients in the United States of America (<xref ref-type="bibr" rid="ref14">14</xref>, <xref ref-type="bibr" rid="ref15">15</xref>). This was later replicated in another study (<xref ref-type="bibr" rid="ref16">16</xref>). Similarly, the proportion of women in the presurgical evaluation for DBS was lower, but the likelihood of positive approval was higher for women than for men (<xref ref-type="bibr" rid="ref16">16</xref>). Nevertheless, the proportion of women undergoing DBS was lower in women than in men (<xref ref-type="bibr" rid="ref16">16</xref>). Another study reported that men were overrepresented in DBS treatment compared to the total number of hospitalizations of patients with PD (<xref ref-type="bibr" rid="ref17">17</xref>). Dalrymple et al. examined differences based on the primary indication for DBS. They demonstrated that men were more likely to be treated with DBS for medication refractory tremor than women (<xref ref-type="bibr" rid="ref18">18</xref>). Interestingly, Vinke et al. reported that more women underwent STN-DBS surgery after moving from awake to asleep surgery (<xref ref-type="bibr" rid="ref19">19</xref>).</p>
</sec>
<sec id="sec6">
<title>Gender-specific perspective towards STN-DBS</title>
<p>A study that examined gender disparity from diagnosis to DBS found no gender differences in the interval between diagnosis and surgery or DBS outcomes (<xref ref-type="bibr" rid="ref20">20</xref>). Interestingly, women had a greater reduction in motor scores before surgery ON medication than men (<xref ref-type="bibr" rid="ref20">20</xref>). On the other hand, women were more likely to be rejected for DBS because of depression at presurgical evaluation (<xref ref-type="bibr" rid="ref16">16</xref>) and they were more likely to decide against DBS because of personal preference (<xref ref-type="bibr" rid="ref21">21</xref>). Men, on the other hand, were more likely not to receive DBS because they had been lost to follow-up in the outpatient clinic before the decision whether to operate has been made (<xref ref-type="bibr" rid="ref21">21</xref>). One study examined the gender-specific patterns in the decision-making process before DBS (<xref ref-type="bibr" rid="ref22">22</xref>) and found that while the male decision-making process was mostly characterized by &#x201C;taking own initiative&#x201D; and &#x201C;agreeing when offered&#x201D;, the female decision-making process was also characterized by &#x201C;hesitation and waiting&#x201D;. Women were also more afraid of complications and needed more support from their social environment during the presurgical evaluation (<xref ref-type="bibr" rid="ref22">22</xref>). In contrast, two other studies found no difference between the arguments for and against DBS (<xref ref-type="bibr" rid="ref16">16</xref>, <xref ref-type="bibr" rid="ref23">23</xref>).</p>
</sec>
</sec>
<sec id="sec7">
<title>Gender differences in clinical outcomes in PD patients treated with STN-DBS</title>
<sec id="sec8">
<title>Motor symptoms</title>
<p>Regarding motor symptoms, a total of 14 studies were analysed, five of which reported better improvement in overall motor scores or subscores in male STN-DBS PD patients and two reported better motor improvement in female STN-DBS PD patients. Most studies reported equal improvement in overall motor function in male and female patients after STN-DBS (<xref ref-type="bibr" rid="ref16">16</xref>, <xref ref-type="bibr" rid="ref24 ref25 ref26 ref27 ref28 ref29 ref30 ref31">24&#x2013;31</xref>). However, three studies reported unequal improvement within bradykinesia subscores (<xref ref-type="bibr" rid="ref16">16</xref>, <xref ref-type="bibr" rid="ref30">30</xref>, <xref ref-type="bibr" rid="ref32">32</xref>). Accolla et al. reported equal improvement in total motor scores, but men improved significantly more than women in Unified Parkinson&#x2019;s Disease Rating Scale (UPDRS) percentage scores for bradykinesia and in absolute hand tapping test scores (<xref ref-type="bibr" rid="ref30">30</xref>). This is consistent with the findings of Jost et al. who found that total motor scores improved equally in men and women, but bradykinesia improved significantly more in men than in women (<xref ref-type="bibr" rid="ref16">16</xref>). Interestingly, Yuan et al. demonstrated that both genders improved significantly in &#x201C;OFF medication-ON stimulation&#x201D; conditions, but only men improved in the &#x201C;ON medication-ON stimulation&#x201D; conditions. This was reported for total scores and most subscores, including the bradykinesia subscore (<xref ref-type="bibr" rid="ref32">32</xref>).</p>
<p>In a long-term longitudinal study, it was found that the overall motor scores of men improved more than those of women at 1&#x2009;year follow-up (<xref ref-type="bibr" rid="ref33">33</xref>). This was related to worse limb akinesia and gait in women than men. However, at 3- and 5&#x2009;years follow-up, both genders improved equally. Interestingly, only women significantly improved in postural stability. This could be due to women having better overall motor scores, lower score for limb akinesia and lower axial subscore before surgery (<xref ref-type="bibr" rid="ref33">33</xref>). Another long-term study found equal improvement for total motor scores and subdomains (bradykinesia, axial, rigidity, and tremor) in men and women at 1&#x2009;year follow-up (<xref ref-type="bibr" rid="ref25">25</xref>). However, at 5&#x2009;years follow-up, total motor scores improved equally, but tremor improved significantly only in women (<xref ref-type="bibr" rid="ref25">25</xref>). In the longest reported follow-up study, they looked at post-surgical motor outcomes in &#x201C;ON medication-ON stimulation&#x201D; conditions (<xref ref-type="bibr" rid="ref34">34</xref>). They found that motor scores and bradykinesia subscores deteriorated in women from 5&#x2009;years after surgery, but in men from 10&#x2009;years after surgery. Furthermore, at 1&#x2009;year follow-up, only men had improvement in rigidity. Women had lower tremor subscores at all times after surgery, but the tremor subscore did not change significantly in neither men nor in women. It is worth mentioning that at baseline women had better total motor scores ON medication, less tremor and less dyskinesias compared to men (<xref ref-type="bibr" rid="ref34">34</xref>).</p>
<p>In a retrospective study, specifically looking into postural abnormalities, the authors reported that male gender was a predictive factor for upper camptocormia after STN-DBS (<xref ref-type="bibr" rid="ref35">35</xref>). Two other studies, looking into possible predictive factors for motor improvement, did not find gender as a significant predictive factor for postural abnormalities (<xref ref-type="bibr" rid="ref31">31</xref>, <xref ref-type="bibr" rid="ref36">36</xref>). One of these studies reported that in women with PD preoperative levodopa responsiveness was a better predictor for motor improvement than for male patients (<xref ref-type="bibr" rid="ref31">31</xref>). Chiou et al. also examined gender-specific predictive factors: men had better motor improvement if they had lower levodopa equivalent daily dose (LEDD) preoperatively, worse motor scores including tremor, or better response to medication of tremor and rigidity (<xref ref-type="bibr" rid="ref29">29</xref>). On the other hand, women had better motor improvement after surgery if they had worse motor scores preoperatively, better Activities of Daily Living (ADL), or better medication response of akinesia (<xref ref-type="bibr" rid="ref29">29</xref>).</p>
</sec>
<sec id="sec9">
<title>Levodopa equivalent daily dose</title>
<p>Regarding LEDD, a total of eight studies were reviewed, with two reporting a greater LEDD reduction in male patients (<xref ref-type="bibr" rid="ref24">24</xref>, <xref ref-type="bibr" rid="ref37">37</xref>). One 10&#x2009;years follow-up study reported a significant LEDD reduction only in men but not in women LEDD in whom LEDD returned to values before surgery at 5&#x2009;years after the surgery (<xref ref-type="bibr" rid="ref34">34</xref>). However, other studies did not report differences in LEDD reduction between genders (<xref ref-type="bibr" rid="ref20">20</xref>, <xref ref-type="bibr" rid="ref21">21</xref>, <xref ref-type="bibr" rid="ref25">25</xref>, <xref ref-type="bibr" rid="ref30">30</xref>, <xref ref-type="bibr" rid="ref33">33</xref>).</p>
</sec>
</sec>
<sec id="sec10">
<title>Cognition and psychological outcomes</title>
<sec id="sec11">
<title>Cognition</title>
<p>Regarding cognition, a total of seven studies were reviewed, with three reporting improvement or better prognosis of cognition in female patients. Although it is known that STN-DBS does not lead to a decline in general cognitive abilities (<xref ref-type="bibr" rid="ref38">38</xref>, <xref ref-type="bibr" rid="ref39">39</xref>), one study found that male gender was a predictive factor for the development of dementia after STN-DBS (<xref ref-type="bibr" rid="ref40">40</xref>). In addition, another study found that only women showed significant improvement on cognitive tests after STN-DBS (<xref ref-type="bibr" rid="ref26">26</xref>). While one study reported improvement in the cognitive domain of the quality of life scale PDQ-39 after STN-DBS (<xref ref-type="bibr" rid="ref28">28</xref>), another study found no difference in the cognitive domain of the PDQ-39 between genders (<xref ref-type="bibr" rid="ref16">16</xref>). Other studies report no significant differences in cognition in both men and women after STN-DBS (<xref ref-type="bibr" rid="ref24">24</xref>, <xref ref-type="bibr" rid="ref25">25</xref>, <xref ref-type="bibr" rid="ref32">32</xref>).</p>
</sec>
<sec id="sec12">
<title>Depression</title>
<p>Regarding depression, a total of seven studies were reviewed (<xref ref-type="bibr" rid="ref24 ref25 ref26 ref27">24&#x2013;27</xref>, <xref ref-type="bibr" rid="ref32">32</xref>, <xref ref-type="bibr" rid="ref41">41</xref>, <xref ref-type="bibr" rid="ref42">42</xref>), with one study reporting greater improvement in depression in female patients (<xref ref-type="bibr" rid="ref41">41</xref>) and one study reporting greater improvement in depression in male patients after STN-DBS (<xref ref-type="bibr" rid="ref26">26</xref>). Furthermore, a longitudinal study reported that women had more depressive symptoms in all phases of STN-DBS surgery and LEDD was positively correlated with depressive symptoms only in women (<xref ref-type="bibr" rid="ref27">27</xref>). Although depressive symptoms appeared to decrease more in women than in men, further analysis showed significant modulation by gender, but not for STN-DBS time or the interaction between STN-DBS time and gender (<xref ref-type="bibr" rid="ref27">27</xref>). Importantly, this and other studies consistently reported that women had more severe depressive symptoms than men before surgery (<xref ref-type="bibr" rid="ref24">24</xref>, <xref ref-type="bibr" rid="ref27">27</xref>, <xref ref-type="bibr" rid="ref32">32</xref>, <xref ref-type="bibr" rid="ref41">41</xref>). In general, most other studies showed equal improvement in depression in both genders (<xref ref-type="bibr" rid="ref24">24</xref>, <xref ref-type="bibr" rid="ref25">25</xref>, <xref ref-type="bibr" rid="ref32">32</xref>, <xref ref-type="bibr" rid="ref42">42</xref>).</p>
</sec>
<sec id="sec13">
<title>Impulsivity and impulsive disorders</title>
<p>With regard to impulsivity and impulsive disorders, a total of three studies were analysed, one of which found an improvement in impulsivity only in men with PD after STN-DBS (<xref ref-type="bibr" rid="ref26">26</xref>), and two reporting an increase in impulsivity behaviour in women. Namely, a study examining impulse control behaviours (ICB) after STN-DBS, reported that more women developed new-onset ICB than men, resulting in a higher prevalence of ICB in women (<xref ref-type="bibr" rid="ref43">43</xref>). In addition, one study examined loss-chasing behaviour as part of gambling behaviour, which is a form of impulse control disorders (ICD) (<xref ref-type="bibr" rid="ref44">44</xref>), and found that the value of chasing losses increased more in women than men with STN-DBS.</p>
</sec>
<sec id="sec14">
<title>Anxiety</title>
<p>Anxiety was measured in two studies, with one study reporting higher anxiety symptoms in women before surgery (<xref ref-type="bibr" rid="ref32">32</xref>), but neither study found significant improvement in anxiety in men or women after surgery (<xref ref-type="bibr" rid="ref32">32</xref>, <xref ref-type="bibr" rid="ref42">42</xref>).</p>
</sec>
<sec id="sec15">
<title>Personality</title>
<p>One study examined the possible personality changes after STN-DBS, in which no significant differences in personality were found before and after STN-DBS in neither men nor women with STN-DBS (<xref ref-type="bibr" rid="ref27">27</xref>).</p>
</sec>
</sec>
<sec id="sec16">
<title>Other non-motor symptoms</title>
<p>Regarding non-motor symptoms in general, a total of four studies were reported, with one study reporting an improvement in certain non-motor symptoms in male or female PD patients with STN-DBS (<xref ref-type="bibr" rid="ref16">16</xref>). STN-DBS improves the non-motor symptoms as measured by the Non-Motor Symptoms Scale (NMSS) total score (<xref ref-type="bibr" rid="ref16">16</xref>, <xref ref-type="bibr" rid="ref45">45</xref>), regardless of gender, but women improved significantly on the questions on attention and memory and men on the questions on mood and apathy and perceptual problems and hallucinations (<xref ref-type="bibr" rid="ref16">16</xref>). However, when looking at non-motor symptoms as measured by UPDRS part I, two studies found no significant improvement for neither men nor women after STN-DBS (<xref ref-type="bibr" rid="ref24">24</xref>, <xref ref-type="bibr" rid="ref26">26</xref>).</p>
<sec id="sec17">
<title>Voice</title>
<p>With regard to the voice, a total of four studies were analysed, two of which reported changes in voice characteristics in men and one of which reported changes in voice characteristics in women with PD after STN-DBS. Namely, Lee et al. demonstrated that only men showed improvement in correlation dimension as a measure for voice quality after STN-DBS compared to patients with PD patients without STN-DBS (<xref ref-type="bibr" rid="ref46">46</xref>). In addition, two other studies reported that women showed worsening on more voice characteristics (e.g., jitter and shimmer) than men (<xref ref-type="bibr" rid="ref47">47</xref>, <xref ref-type="bibr" rid="ref48">48</xref>) and also improvement on less voice characteristics compared to men OFF stimulation (<xref ref-type="bibr" rid="ref47">47</xref>), but the results were statistically significant in only one study (<xref ref-type="bibr" rid="ref47">47</xref>). Interestingly, another study found that only women showed several significant changes in voice characteristics with different medication and stimulation conditions (<xref ref-type="bibr" rid="ref49">49</xref>).</p>
</sec>
<sec id="sec18">
<title>Weight</title>
<p>Regarding weight change after STN-DBS, a total of four studies were analysed, three of which reported gender-specific differences in certain characteristics of weight change after STN-DBS. In general, studies show that men and women endure weight gain after STN-DBS (<xref ref-type="bibr" rid="ref50 ref51 ref52">50&#x2013;52</xref>). Regarding possible gender differences in weight gain, a study showed that after STN-DBS body mass index (BMI) increased more in women than in men (<xref ref-type="bibr" rid="ref53">53</xref>). Furthermore, in two of these studies both fat-free mass and fat mass increased in men, while only fat mass increased in women (<xref ref-type="bibr" rid="ref51">51</xref>, <xref ref-type="bibr" rid="ref52">52</xref>).</p>
</sec>
<sec id="sec19">
<title>Sexual functions</title>
<p>Regarding sexual outcomes, a total of four studies were analysed, one of which reported worse scores in men and one reported improvement of sexual functions in men with PD after STN-DBS. Two studies did not find overall improvement or any gender differences after STN-DBS (<xref ref-type="bibr" rid="ref42">42</xref>, <xref ref-type="bibr" rid="ref54">54</xref>) in sexual functions, with Castelli et al. reporting that only men improved on the dissatisfaction subscore of the reduced version of the Gollombok Rust inventory of sexual satisfaction (GRISS) (<xref ref-type="bibr" rid="ref42">42</xref>, <xref ref-type="bibr" rid="ref55">55</xref>). When considering male patients under 60&#x2009;years, total improvement of sexual functions was observed on the reduced version of the GRISS (<xref ref-type="bibr" rid="ref42">42</xref>). On contrary, one study reported that men had worse scores in sexual functions measured by NMSS after STN-DBS (<xref ref-type="bibr" rid="ref16">16</xref>), Interestingly, Pedro et al. found that age was a predictor of sexual dysfunction in both sexes, but quality of life (QoL) was better in men with erectile dysfunction than in women with sexual dysfunction (<xref ref-type="bibr" rid="ref54">54</xref>).</p>
</sec>
<sec id="sec20">
<title>Urinary dysfunction</title>
<p>Two studies have investigated urinary symptoms and observed improvements in urinary outcomes (urinary incontinence and frequency) for both men and women (<xref ref-type="bibr" rid="ref56">56</xref>, <xref ref-type="bibr" rid="ref57">57</xref>). However, one of these studies, which also included urodynamic tests, specifically reported that women demonstrated improvements in more urinary outcomes, such as residual urine and American Urological Association Symptom Index, than men (<xref ref-type="bibr" rid="ref57">57</xref>).</p>
</sec>
<sec id="sec21">
<title>Pain</title>
<p>One study investigated pain scores showed that only men with PD improved significantly in total pain scores after STN-DBS. Nevertheless, men had more improvement in the subdomains of musculoskeletal and chronic pain (<xref ref-type="bibr" rid="ref37">37</xref>).</p>
</sec>
<sec id="sec22">
<title>Restless legs syndrome</title>
<p>A study investigated restless legs syndrome (RLS) and showed better improvement in men than in women with PD after STN-DBS (<xref ref-type="bibr" rid="ref32">32</xref>).</p>
</sec>
</sec>
<sec id="sec23">
<title>Other outcomes</title>
<sec id="sec24">
<title>Quality of Life</title>
<p>With regards to QoL and its subdomains, a total of six studies were analysed, three of which reported a better improvement of QoL in men and two in women. Men improve more in QoL (<xref ref-type="bibr" rid="ref32">32</xref>) and on more subdomains than women (<xref ref-type="bibr" rid="ref16">16</xref>, <xref ref-type="bibr" rid="ref25">25</xref>, <xref ref-type="bibr" rid="ref32">32</xref>) as measured by the PDQ-39 (<xref ref-type="bibr" rid="ref58">58</xref>), PDQ-8 (<xref ref-type="bibr" rid="ref59">59</xref>), and SF-36 (<xref ref-type="bibr" rid="ref60">60</xref>). In contrast, Dietrich et al. demonstrated that women showed more improvement in QoL than men (<xref ref-type="bibr" rid="ref27">27</xref>) and Hariz et al. reported that only women showed improvement in QoL and on more subdomains as measured by the PDQ-39 (<xref ref-type="bibr" rid="ref28">28</xref>).</p>
</sec>
<sec id="sec25">
<title>Activities of daily living</title>
<p>Regarding ADL, a total of nine studies were analysed, with one reporting gender-related differences of ADL after STN-DBS. Namely, after STN-DBS female gender could be a predictive factor for functional dependence (defined as an ADL score below 80%) as measured by the Schwab and England Activities of Daily Living Scale (<xref ref-type="bibr" rid="ref61">61</xref>, <xref ref-type="bibr" rid="ref62">62</xref>). However, most studies report equal significant improvement in ADL in both men and women after STN-DBS (<xref ref-type="bibr" rid="ref24 ref25 ref26">24&#x2013;26</xref>, <xref ref-type="bibr" rid="ref28 ref29 ref30">28&#x2013;30</xref>, <xref ref-type="bibr" rid="ref32">32</xref>, <xref ref-type="bibr" rid="ref33">33</xref>).</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion" id="sec26">
<title>Discussion</title>
<p>The aim of this review was to examine gender discrepancies and gender differences in clinical outcomes in PD patients treated with STN-DBS. Evidence from the articles, suggests that there are significant gender discrepancies and differences in clinical outcomes in STN-DBS PD patients. The gender differences in clinical outcomes appear to be more pronounced for cognitive and psychological functions, and other non-motor symptoms than for motor symptoms, although there are also significant gender differences for motor symptoms.</p>
<p>Regarding gender discrepancies, men are more likely than women to receive DBS (<xref ref-type="bibr" rid="ref14">14</xref>, <xref ref-type="bibr" rid="ref15">15</xref>), and their indications differ from women (<xref ref-type="bibr" rid="ref18">18</xref>). Our observation that men are more likely to receive DBS is in line with a meta-analysis performed by Hariz et al., who also found a global male predominance, except for Asia (<xref ref-type="bibr" rid="ref63">63</xref>). This could be related to referral bias for surgery in men (<xref ref-type="bibr" rid="ref13">13</xref>). In addition, the evidence suggests that during the decision-making process for DBS-use, women are more influenced by personal preferences and external factors such as surgical approach and social environment (<xref ref-type="bibr" rid="ref19">19</xref>, <xref ref-type="bibr" rid="ref21">21</xref>, <xref ref-type="bibr" rid="ref22">22</xref>). Another possible reason could lie in contraindications for STN-DBS, such as depressive symptoms (<xref ref-type="bibr" rid="ref16">16</xref>), which are often more severe in women than in men (<xref ref-type="bibr" rid="ref13">13</xref>).</p>
<p>With regard to gender differences in clinical outcomes, motor symptoms show improvement in both genders (<xref ref-type="bibr" rid="ref16">16</xref>, <xref ref-type="bibr" rid="ref24 ref25 ref26 ref27 ref28 ref29 ref30 ref31">24&#x2013;31</xref>), even in long-term follow-up (<xref ref-type="bibr" rid="ref25">25</xref>). Men may exhibit more improvement in bradykinesia subscores (<xref ref-type="bibr" rid="ref16">16</xref>, <xref ref-type="bibr" rid="ref30">30</xref>). Interestingly, within the general PD population gender differences are seen in some motor symptoms, such as more dyskinesias and tremor-dominant PD in women (<xref ref-type="bibr" rid="ref13">13</xref>, <xref ref-type="bibr" rid="ref64">64</xref>, <xref ref-type="bibr" rid="ref65">65</xref>), but not in bradykinesia. Therefore, a possible gender-specific difference in the bradykinesia response to STN-DBS is not clear and requires further research. LEDD reduction seems to be more frequent in men than women (<xref ref-type="bibr" rid="ref24">24</xref>). A possible explanation could be that women are set at lower LEDD values before surgery (<xref ref-type="bibr" rid="ref13">13</xref>), which could explain less reduction. However, these pre-surgical lower LEDD values in combination with less improvement in women was only seen in one study (<xref ref-type="bibr" rid="ref24">24</xref>). Regarding cognition, the effect of DBS seems to be uncertain, but men may be more susceptible to cognitive decline (<xref ref-type="bibr" rid="ref40">40</xref>), while women show more frequent improvement in cognitive functioning (<xref ref-type="bibr" rid="ref26">26</xref>). In general, women seem to outperform men in cognitive tests (<xref ref-type="bibr" rid="ref13">13</xref>), but this does not necessarily explain a possible gender-specific difference in improvement after STN-DBS. Prior to surgery, women exhibit more severe depressive symptoms (<xref ref-type="bibr" rid="ref24">24</xref>, <xref ref-type="bibr" rid="ref27">27</xref>, <xref ref-type="bibr" rid="ref32">32</xref>, <xref ref-type="bibr" rid="ref41">41</xref>), which is also observed in the general PD population (<xref ref-type="bibr" rid="ref13">13</xref>). However, there is evidence of general improvement of depression in both genders after STN-DBS (<xref ref-type="bibr" rid="ref24">24</xref>, <xref ref-type="bibr" rid="ref32">32</xref>). Regarding impulsivity, only men showed improvement in impulsivity scores (<xref ref-type="bibr" rid="ref26">26</xref>), while women experienced worsening in various impulsivity domains (<xref ref-type="bibr" rid="ref43">43</xref>, <xref ref-type="bibr" rid="ref44">44</xref>). This could be explained by the fact that men with PD are more likely to have an ICD (<xref ref-type="bibr" rid="ref13">13</xref>, <xref ref-type="bibr" rid="ref65">65</xref>) and therefore are more likely to show improvement in these symptoms. Another explanation would be that LEDD decreases more often in men after STN-DBS (<xref ref-type="bibr" rid="ref24">24</xref>), which could be associate with improvement in ICD (<xref ref-type="bibr" rid="ref66">66</xref>). Even though some studies suggest possible personality changes after STN-DBS (<xref ref-type="bibr" rid="ref67">67</xref>), personality traits or anxiety do not appear to change in both genders (<xref ref-type="bibr" rid="ref27">27</xref>, <xref ref-type="bibr" rid="ref32">32</xref>, <xref ref-type="bibr" rid="ref42">42</xref>). Regarding other non-motor symptoms, the evidence is not clear as to whether there is an overall improvement (<xref ref-type="bibr" rid="ref24">24</xref>, <xref ref-type="bibr" rid="ref26">26</xref>). Nevertheless, men tend to demonstrate improvement in voice quality (<xref ref-type="bibr" rid="ref46">46</xref>), while women are more susceptible to voice deterioration (<xref ref-type="bibr" rid="ref47">47</xref>). In general, STN-DBS seems to lead to deterioration of speech and voice quality (<xref ref-type="bibr" rid="ref68">68</xref>), and any potential gender differences could maybe be explained by sex-specific anatomical differences (<xref ref-type="bibr" rid="ref47">47</xref>). Men also show weight gain in fat free mass and fat mass (<xref ref-type="bibr" rid="ref51">51</xref>, <xref ref-type="bibr" rid="ref52">52</xref>), while women only gain weight in fat mass (<xref ref-type="bibr" rid="ref51">51</xref>, <xref ref-type="bibr" rid="ref52">52</xref>). This weight gain for both seems to be explained by a decreased energy expenditure, but unchanged energy intake after surgery (<xref ref-type="bibr" rid="ref53">53</xref>), while the gender-specific body composition change seems to be explained by a general hormonal difference and response between men and women, known from other fields of research (<xref ref-type="bibr" rid="ref69">69</xref>). Regarding sexual functions, the results of relevant studies are inconsistent, which leads to the conclusion that there is no clear evidence of improvement in sexual function for both genders after STN-DBS (<xref ref-type="bibr" rid="ref42">42</xref>, <xref ref-type="bibr" rid="ref54">54</xref>). Urinary symptoms improve in both men and women (<xref ref-type="bibr" rid="ref56">56</xref>), with women seeming to experience a broader range of benefits on urinary symptoms (<xref ref-type="bibr" rid="ref57">57</xref>). Despite the limited amount of relevant studies, only men appear to improve in pain scores (<xref ref-type="bibr" rid="ref37">37</xref>) and show improvement in RLS (<xref ref-type="bibr" rid="ref32">32</xref>). Regarding QoL, conflicting evidence remains which gender benefits more (<xref ref-type="bibr" rid="ref25">25</xref>, <xref ref-type="bibr" rid="ref27">27</xref>, <xref ref-type="bibr" rid="ref28">28</xref>, <xref ref-type="bibr" rid="ref32">32</xref>), while both genders show improvement in ADL (<xref ref-type="bibr" rid="ref24 ref25 ref26">24&#x2013;26</xref>, <xref ref-type="bibr" rid="ref29">29</xref>, <xref ref-type="bibr" rid="ref30">30</xref>, <xref ref-type="bibr" rid="ref33">33</xref>).</p>
<p>In general, possible gender mechanisms influencing movement disorders and their effect on STN-DBS could be explained by sexual dimorphism, genetics and hormones (<xref ref-type="bibr" rid="ref70">70</xref>). Sexual dimorphism seems to be relevant in the neurological system (<xref ref-type="bibr" rid="ref71">71</xref>). A meta-analysis examining sexual dimorphism in neural structure found that men generally have larger brain volume and exhibit differences in the volume and density of specific brain regions compared to women (<xref ref-type="bibr" rid="ref72">72</xref>). Imaging studies show that PD leads to atrophy of the brain (<xref ref-type="bibr" rid="ref73">73</xref>, <xref ref-type="bibr" rid="ref74">74</xref>). Interestingly, men with PD seem to show decreased cortical thickness in multiple brain regions compared to healthy controls, which suggests more cognitive decline in men with PD than women with PD (<xref ref-type="bibr" rid="ref75">75</xref>). Furthermore, when investigating neural activity, in studies involving healthy individuals, it has been reported that women exhibit higher beta power compared to men (<xref ref-type="bibr" rid="ref76">76</xref>, <xref ref-type="bibr" rid="ref77">77</xref>). In addition, in PD patients undergoing STN-DBS, gender differences in neural activity have been observed (<xref ref-type="bibr" rid="ref78">78</xref>). Compared to men, women with PD displayed higher power in the alpha/low-beta bands OFF medication, as well as higher gamma and 300&#x2009;Hz rhythm bands ON medication (<xref ref-type="bibr" rid="ref78">78</xref>). These findings suggest that there are gender differences in the general anatomical structure and neural activity, which may potentially contribute to different responses to DBS that aims to normalise neural activity. There seem to be some gender differences within genetics in PD (<xref ref-type="bibr" rid="ref70">70</xref>). X and Y chromosomes seem to individually influence the pathogenesis of PD (<xref ref-type="bibr" rid="ref79">79</xref>), which could lead to a difference between genders. When looking specifically into genes, it seems that there are differences in the expression and functioning of dopaminergic and substantia nigra genes between genders, which could contribute to gender differences in PD presentation and response to treatment (<xref ref-type="bibr" rid="ref80">80</xref>, <xref ref-type="bibr" rid="ref81">81</xref>). The hormonal environment of women differs from men, which could explain gender differences. Sex hormones affect the brain, which contribute to gender differences in neural function (<xref ref-type="bibr" rid="ref82">82</xref>). This seems to be the in particularly the case for oestrogen (<xref ref-type="bibr" rid="ref82">82</xref>). Oestrogen has a pro-dopaminergic effect, independent of oestrogen receptors, which protects against the pathogenesis of PD (<xref ref-type="bibr" rid="ref79">79</xref>, <xref ref-type="bibr" rid="ref83">83</xref>). On the other hand, androgens do not exert a similar neuroprotective effect (<xref ref-type="bibr" rid="ref79">79</xref>). These gender differences in hormones could possibly contribute to the gender-specific effects of STN-DBS.</p>
<p>Lastly, the psychological perception and social environment of women differ from men. Women are known to endure more emotional disorders, such as depression (<xref ref-type="bibr" rid="ref84">84</xref>, <xref ref-type="bibr" rid="ref85">85</xref>). There seems to be a role for female-specific factors, such as coping and reporting, influencing the disease presentation (<xref ref-type="bibr" rid="ref85">85</xref>). Their different emotional perception could contribute to a difference in perceived effect, especially for subjective measures, such as questionnaires. Furthermore, women often have a major role in their household and corresponding chores (<xref ref-type="bibr" rid="ref86">86</xref>), which could possibly influence the rate and perception of recovery, after STN-DBS.</p>
<p>Future research should focus directly on the study of gender differences. By focusing specifically on gender outcomes in a prospective setting, rather than reporting them as a secondary outcome, potential problems with multiple testing can be avoided. In addition, more studies should include non-surgical control groups and directly compare gender groups rather than simply reporting differences within each gender group before and after surgery. These approaches will contribute to a more accurate and comprehensive understanding of sex differences in PD patients treated with STN-DBS.</p>
<p>In summary, there appears to be evidence of gender discrepancies and gender differences in clinical outcomes in PD patients treated with STN-DBS. These findings are partially consistent with gender differences in the general PD population. High quality future research focusing specifically on gender differences in PD patients treated with STN-DBS is needed to better understand gender differences in STN-DBS PD patients. This may have important clinical implications for patient selection, outcome prediction and management of PD patients treated with STN-DBS.</p>
</sec>
<sec sec-type="data-availability" id="sec27">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">Supplementary material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec sec-type="author-contributions" id="sec28">
<title>Author contributions</title>
<p>MH: Data curation, Formal analysis, Investigation, Project administration, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. RV: Funding acquisition, Supervision, Validation, Writing &#x2013; review &#x0026; editing. DG: Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Writing &#x2013; review &#x0026; editing.</p>
</sec>
</body>
<back>
<sec sec-type="funding-information" id="sec29">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The publishing of this study is funded by project grant number 20230063 from the Ministry of Health of the Republic of Slovenia granted to DG. This funder will cover the article publishing charges (APC).</p>
</sec>
<sec sec-type="COI-statement" id="sec30">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="sec100" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="sec31">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fneur.2023.1257781/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fneur.2023.1257781/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.DOCX" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>DeMaagd</surname> <given-names>G</given-names></name> <name><surname>Philip</surname> <given-names>A</given-names></name></person-group>. <article-title>Parkinson&#x2019;s disease and its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis</article-title>. <source>P T</source>. (<year>2015</year>) <volume>40</volume>:<fpage>504</fpage>&#x2013;<lpage>32</lpage>. PMID: <pub-id pub-id-type="pmid">26236139</pub-id></citation></ref>
<ref id="ref2"><label>2.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reichmann</surname> <given-names>H</given-names></name></person-group>. <article-title>Clinical criteria for the diagnosis of Parkinson&#x2019;s disease</article-title>. <source>Neurodegener Dis</source>. (<year>2010</year>) <volume>7</volume>:<fpage>284</fpage>&#x2013;<lpage>90</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000314478</pub-id></citation></ref>
<ref id="ref3"><label>3.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zesiewicz</surname> <given-names>TA</given-names></name> <name><surname>Sullivan</surname> <given-names>KL</given-names></name> <name><surname>Hauser</surname> <given-names>RA</given-names></name></person-group>. <article-title>Nonmotor symptoms of Parkinson&#x2019;s disease</article-title>. <source>Expert Rev Neurother</source>. (<year>2006</year>) <volume>6</volume>:<fpage>1811</fpage>&#x2013;<lpage>22</lpage>. doi: <pub-id pub-id-type="doi">10.1586/14737175.6.12.1811</pub-id></citation></ref>
<ref id="ref4"><label>4.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hariz</surname> <given-names>M</given-names></name> <name><surname>Blomstedt</surname> <given-names>P</given-names></name></person-group>. <article-title>Deep brain stimulation for Parkinson&#x2019;s disease</article-title>. <source>J Intern Med</source>. (<year>2022</year>) <volume>292</volume>:<fpage>764</fpage>&#x2013;<lpage>78</lpage>. doi: <pub-id pub-id-type="doi">10.1111/joim.13541</pub-id></citation></ref>
<ref id="ref5"><label>5.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zibetti</surname> <given-names>M</given-names></name> <name><surname>Merola</surname> <given-names>A</given-names></name> <name><surname>Rizzi</surname> <given-names>L</given-names></name> <name><surname>Ricchi</surname> <given-names>V</given-names></name> <name><surname>Angrisano</surname> <given-names>S</given-names></name> <name><surname>Azzaro</surname> <given-names>C</given-names></name></person-group>. <article-title>Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson&#x2019;s disease</article-title>. <source>Mov Disord</source>. (<year>2011</year>) <volume>26</volume>:<fpage>2327</fpage>&#x2013;<lpage>34</lpage>. doi: <pub-id pub-id-type="doi">10.1002/mds.23903</pub-id>, PMID: <pub-id pub-id-type="pmid">22012750</pub-id></citation></ref>
<ref id="ref6"><label>6.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bove</surname> <given-names>F</given-names></name> <name><surname>Mulas</surname> <given-names>D</given-names></name> <name><surname>Cavallieri</surname> <given-names>F</given-names></name> <name><surname>Castrioto</surname> <given-names>A</given-names></name> <name><surname>Chabardes</surname> <given-names>S</given-names></name></person-group>. <article-title>Long-term outcomes (15 years) after subthalamic nucleus deep brain stimulation in patients with Parkinson disease</article-title>. <source>Neurology</source>. (<year>2021</year>) <volume>97</volume>:<fpage>12246</fpage>. doi: <pub-id pub-id-type="doi">10.1212/WNL.0000000000012246</pub-id></citation></ref>
<ref id="ref7"><label>7.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Castrioto</surname> <given-names>A</given-names></name> <name><surname>Lozano</surname> <given-names>AM</given-names></name> <name><surname>Poon</surname> <given-names>YY</given-names></name> <name><surname>Lang</surname> <given-names>AE</given-names></name> <name><surname>Fallis</surname> <given-names>M</given-names></name> <name><surname>Moro</surname> <given-names>E</given-names></name></person-group>. <article-title>Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation</article-title>. <source>Arch Neurol</source>. (<year>2011</year>) <volume>68</volume>:<fpage>1550</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1001/archneurol.2011.182</pub-id>, PMID: <pub-id pub-id-type="pmid">21825213</pub-id></citation></ref>
<ref id="ref8"><label>8.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alves</surname> <given-names>G</given-names></name> <name><surname>Muller</surname> <given-names>B</given-names></name> <name><surname>Herlofson</surname> <given-names>K</given-names></name> <name><surname>HogenEsch</surname> <given-names>I</given-names></name> <name><surname>Telstad</surname> <given-names>W</given-names></name> <name><surname>Aarsland</surname> <given-names>D</given-names></name></person-group>. <article-title>Incidence of Parkinson&#x2019;s disease in Norway: the Norwegian Parkwest study</article-title>. <source>J Neurol Neurosurg Psychiatry</source>. (<year>2009</year>) <volume>80</volume>:<fpage>851</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1136/jnnp.2008.168211</pub-id></citation></ref>
<ref id="ref9"><label>9.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haaxma</surname> <given-names>CA</given-names></name> <name><surname>Bloem</surname> <given-names>BR</given-names></name> <name><surname>Borm</surname> <given-names>GF</given-names></name> <name><surname>Oyen</surname> <given-names>WJ</given-names></name> <name><surname>Leenders</surname> <given-names>KL</given-names></name></person-group>. <article-title>Gender differences in Parkinson&#x2019;s disease</article-title>. <source>J Neurol Neurosurg Psychiatry</source>. (<year>2007</year>) <volume>78</volume>:<fpage>819</fpage>&#x2013;<lpage>24</lpage>. doi: <pub-id pub-id-type="doi">10.1136/jnnp.2006.103788</pub-id>, PMID: <pub-id pub-id-type="pmid">17098842</pub-id></citation></ref>
<ref id="ref10"><label>10.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Solla</surname> <given-names>P</given-names></name> <name><surname>Cannas</surname> <given-names>A</given-names></name> <name><surname>Ibba</surname> <given-names>FC</given-names></name> <name><surname>Loi</surname> <given-names>F</given-names></name> <name><surname>Corona</surname> <given-names>M</given-names></name> <name><surname>Orofino</surname> <given-names>G</given-names></name></person-group>. <article-title>Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson&#x2019;s disease</article-title>. <source>J Neurol Sci</source>. (<year>2012</year>) <volume>323</volume>:<fpage>33</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jns.2012.07.026</pub-id></citation></ref>
<ref id="ref11"><label>11.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kov&#x00E1;cs</surname> <given-names>M</given-names></name> <name><surname>Makkos</surname> <given-names>A</given-names></name> <name><surname>Aschermann</surname> <given-names>Z</given-names></name> <name><surname>Janszky</surname> <given-names>J</given-names></name> <name><surname>Komoly</surname> <given-names>S</given-names></name> <name><surname>Weintraut</surname> <given-names>R</given-names></name></person-group>. <article-title>Impact of sex on the nonmotor symptoms and the health-related quality of life in Parkinson&#x2019;s disease</article-title>. <source>Parkinsons Dis</source>. (<year>2016</year>) <volume>2016</volume>:<fpage>7951840</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2016/7951840</pub-id>, PMID: <pub-id pub-id-type="pmid">27293959</pub-id></citation></ref>
<ref id="ref12"><label>12.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baldereschi</surname> <given-names>M</given-names></name> <name><surname>Di Carlo</surname> <given-names>A</given-names></name> <name><surname>Rocca</surname> <given-names>WA</given-names></name> <name><surname>Vanni</surname> <given-names>P</given-names></name> <name><surname>Maggi</surname> <given-names>S</given-names></name></person-group>. <article-title>Parkinson&#x2019;s disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. Ilsa working group. Italian longitudinal study on aging</article-title>. <source>Neurology</source>. (<year>2000</year>) <volume>55</volume>:<fpage>1358</fpage>&#x2013;<lpage>63</lpage>. doi: <pub-id pub-id-type="doi">10.1212/wnl.55.9.1358</pub-id>, PMID: <pub-id pub-id-type="pmid">11087781</pub-id></citation></ref>
<ref id="ref13"><label>13.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Georgiev</surname> <given-names>D</given-names></name> <name><surname>Hamberg</surname> <given-names>K</given-names></name> <name><surname>Hariz</surname> <given-names>M</given-names></name> <name><surname>Forsgren</surname> <given-names>L</given-names></name> <name><surname>Hariz</surname> <given-names>GM</given-names></name></person-group>. <article-title>Gender differences in Parkinson&#x2019;s disease: a clinical perspective</article-title>. <source>Acta Neurol Scand</source>. (<year>2017</year>) <volume>136</volume>:<fpage>570</fpage>&#x2013;<lpage>84</lpage>. doi: <pub-id pub-id-type="doi">10.1111/ane.12796</pub-id>, PMID: <pub-id pub-id-type="pmid">28670681</pub-id></citation></ref>
<ref id="ref14"><label>14.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Willis</surname> <given-names>AW</given-names></name> <name><surname>Schootman</surname> <given-names>M</given-names></name> <name><surname>Kung</surname> <given-names>N</given-names></name> <name><surname>Wang</surname> <given-names>XY</given-names></name> <name><surname>Perlmutter</surname> <given-names>JS</given-names></name> <name><surname>Racette</surname> <given-names>BA</given-names></name></person-group>. <article-title>Disparities in deep brain stimulation surgery among insured elders with Parkinson disease</article-title>. <source>Neurology</source>. (<year>2014</year>) <volume>82</volume>:<fpage>163</fpage>&#x2013;<lpage>71</lpage>. doi: <pub-id pub-id-type="doi">10.1212/wnl.0000000000000017</pub-id>, PMID: <pub-id pub-id-type="pmid">24336138</pub-id></citation></ref>
<ref id="ref15"><label>15.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname> <given-names>AK</given-names></name> <name><surname>McGovern</surname> <given-names>RA</given-names></name> <name><surname>Brown</surname> <given-names>LT</given-names></name> <name><surname>Sheehy</surname> <given-names>JP</given-names></name> <name><surname>Zacharia</surname> <given-names>BE</given-names></name></person-group>. <article-title>Disparities in access to deep brain stimulation surgery for Parkinson disease: interaction between African American race and Medicaid use</article-title>. <source>JAMA Neurol</source>. (<year>2014</year>) <volume>71</volume>:<fpage>291</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jamaneurol.2013.5798</pub-id>, PMID: <pub-id pub-id-type="pmid">24395393</pub-id></citation></ref>
<ref id="ref16"><label>16.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jost</surname> <given-names>ST</given-names></name> <name><surname>Strobel</surname> <given-names>L</given-names></name> <name><surname>Rizos</surname> <given-names>A</given-names></name> <name><surname>Loehrer</surname> <given-names>PA</given-names></name> <name><surname>Ashkan</surname> <given-names>K</given-names></name> <name><surname>Evans</surname> <given-names>J</given-names></name></person-group>. <article-title>Gender gap in deep brain stimulation for Parkinson&#x2019;s disease</article-title>. <source>NPJ Parkinsons Dis</source>. (<year>2022</year>) <volume>8</volume>:<fpage>47</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41531-022-00305-y</pub-id>, PMID: <pub-id pub-id-type="pmid">35444187</pub-id></citation></ref>
<ref id="ref17"><label>17.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname> <given-names>G</given-names></name> <name><surname>Morden</surname> <given-names>FTC</given-names></name> <name><surname>Gao</surname> <given-names>F</given-names></name> <name><surname>Morita</surname> <given-names>M</given-names></name> <name><surname>Bruno</surname> <given-names>MK</given-names></name></person-group>. <article-title>Utilization and gender disparities of deep brain stimulation surgery amongst Asian Americans, native Hawaiians, and other Pacific islanders with Parkinson&#x2019;s disease in Hawai;I</article-title>. <source>Clin Neurol Neurosurg</source>. (<year>2022</year>) <volume>222</volume>:<fpage>107466</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.clineuro.2022.107466</pub-id></citation></ref>
<ref id="ref18"><label>18.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dalrymple</surname> <given-names>WA</given-names></name> <name><surname>Pusso</surname> <given-names>A</given-names></name> <name><surname>Sperling</surname> <given-names>SA</given-names></name> <name><surname>Flanigan</surname> <given-names>JL</given-names></name> <name><surname>Huss</surname> <given-names>DS</given-names></name> <name><surname>Harrison</surname> <given-names>MB</given-names></name> <etal/></person-group>. <article-title>Comparison of Parkinson&#x2019;s disease Patients&#x2019; characteristics by indication for deep brain stimulation: men are more likely to have Dbs for tremor</article-title>. <source>Tremor Other Hyperkinet Mov</source>. (<year>2019</year>) <volume>9</volume>:<fpage>676</fpage>. doi: <pub-id pub-id-type="doi">10.7916/tohm.v0.676</pub-id></citation></ref>
<ref id="ref19"><label>19.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vinke</surname> <given-names>RS</given-names></name> <name><surname>Georgiev</surname> <given-names>D</given-names></name> <name><surname>Selvaraj</surname> <given-names>AK</given-names></name> <name><surname>Rahimi</surname> <given-names>T</given-names></name> <name><surname>Bloem</surname> <given-names>BR</given-names></name></person-group>. <article-title>Gender distribution in deep brain stimulation for Parkinson&#x2019;s disease: the effect of awake versus asleep surgery</article-title>. <source>J Parkinsons Dis</source>. (<year>2022</year>) <volume>12</volume>:<fpage>1965</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.3233/JPD-223315</pub-id>, PMID: <pub-id pub-id-type="pmid">35754293</pub-id></citation></ref>
<ref id="ref20"><label>20.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deshpande</surname> <given-names>N</given-names></name> <name><surname>Gibbs</surname> <given-names>R</given-names></name> <name><surname>Ali</surname> <given-names>R</given-names></name></person-group>. <article-title>Evaluation of Dbs timeline in movement disorders: a comparison between genders</article-title>. <source>World Neurosurg</source>. (<year>2022</year>) <volume>164</volume>:<fpage>e256</fpage>&#x2013;<lpage>62</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.wneu.2022.04.092</pub-id></citation></ref>
<ref id="ref21"><label>21.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shpiner</surname> <given-names>DS</given-names></name> <name><surname>Di Luca</surname> <given-names>DG</given-names></name> <name><surname>Cajigas</surname> <given-names>I</given-names></name> <name><surname>Diaz</surname> <given-names>JS</given-names></name> <name><surname>Margolesky</surname> <given-names>J</given-names></name></person-group>. <article-title>Gender disparities in deep brain stimulation for Parkinson&#x2019;s disease</article-title>. <source>Neuromodulation</source>. (<year>2019</year>) <volume>22</volume>:<fpage>484</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1111/ner.12973</pub-id></citation></ref>
<ref id="ref22"><label>22.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hamberg</surname> <given-names>K</given-names></name> <name><surname>Hariz</surname> <given-names>GM</given-names></name></person-group>. <article-title>The decision-making process leading to deep brain stimulation in men and women with Parkinson&#x2019;s disease &#x2013; an interview study</article-title>. <source>BMC Neurol</source>. (<year>2014</year>) <volume>14</volume>:<fpage>89</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1471-2377-14-89</pub-id>, PMID: <pub-id pub-id-type="pmid">24761767</pub-id></citation></ref>
<ref id="ref23"><label>23.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sperens</surname> <given-names>M</given-names></name> <name><surname>Hamberg</surname> <given-names>K</given-names></name> <name><surname>Hariz</surname> <given-names>GM</given-names></name></person-group>. <article-title>Are patients ready for "Earlystim"? Attitudes towards deep brain stimulation among female and male patients with moderately advanced Parkinson&#x2019;s disease</article-title>. <source>Parkinsons Dis</source>. (<year>2017</year>) <volume>2017</volume>:<fpage>1939831</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2017/1939831</pub-id>, PMID: <pub-id pub-id-type="pmid">28458943</pub-id></citation></ref>
<ref id="ref24"><label>24.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chandran</surname> <given-names>S</given-names></name> <name><surname>Krishnan</surname> <given-names>S</given-names></name> <name><surname>Rao</surname> <given-names>RM</given-names></name> <name><surname>Sarma</surname> <given-names>SG</given-names></name> <name><surname>Sarma</surname> <given-names>PS</given-names></name> <name><surname>Kishore</surname> <given-names>A</given-names></name></person-group>. <article-title>Gender influence on selection and outcome of deep brain stimulation for Parkinson&#x2019;s disease</article-title>. <source>Ann Indian Acad Neurol</source>. (<year>2014</year>) <volume>17</volume>:<fpage>66</fpage>&#x2013;<lpage>70</lpage>. doi: <pub-id pub-id-type="doi">10.4103/0972-2327.128557</pub-id>, PMID: <pub-id pub-id-type="pmid">24753663</pub-id></citation></ref>
<ref id="ref25"><label>25.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>R</given-names></name> <name><surname>Yoo</surname> <given-names>D</given-names></name> <name><surname>Choi</surname> <given-names>JH</given-names></name> <name><surname>Shin</surname> <given-names>JH</given-names></name> <name><surname>Park</surname> <given-names>S</given-names></name> <name><surname>Kim</surname> <given-names>HJ</given-names></name></person-group>. <article-title>Sex differences in the short-term and long-term effects of subthalamic nucleus stimulation in Parkinson&#x2019;s disease</article-title>. <source>Parkinsonism Relat Disord</source>. (<year>2019</year>) <volume>68</volume>:<fpage>73</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.parkreldis.2019.09.027</pub-id>, PMID: <pub-id pub-id-type="pmid">31621625</pub-id></citation></ref>
<ref id="ref26"><label>26.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>K&#x00FC;bler</surname> <given-names>D</given-names></name> <name><surname>Astalosch</surname> <given-names>M</given-names></name> <name><surname>Gaus</surname> <given-names>V</given-names></name> <name><surname>Krause</surname> <given-names>P</given-names></name> <name><surname>de Almeida Marcelino</surname> <given-names>AL</given-names></name></person-group>. <article-title>Gender-specific outcomes of deep brain stimulation for Parkinson&#x2019;s disease - results from a single movement disorder center</article-title>. <source>Neurol Sci</source>. (<year>2023</year>) <volume>44</volume>:<fpage>1625</fpage>&#x2013;<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10072-023-06598-y</pub-id></citation></ref>
<ref id="ref27"><label>27.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dietrich</surname> <given-names>AD</given-names></name> <name><surname>Koeppen</surname> <given-names>JA</given-names></name> <name><surname>Buhmann</surname> <given-names>C</given-names></name> <name><surname>Potter-Nerger</surname> <given-names>M</given-names></name> <name><surname>Pinnschmidt</surname> <given-names>HO</given-names></name></person-group>. <article-title>Sex disparities in the self-evaluation of subthalamic deep brain stimulation effects on mood and personality in Parkinson&#x2019;s disease patients</article-title>. <source>Front Neurol</source>. (<year>2020</year>) <volume>11</volume>:<fpage>776</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fneur.2020.00776</pub-id></citation></ref>
<ref id="ref28"><label>28.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hariz</surname> <given-names>GM</given-names></name> <name><surname>Limousin</surname> <given-names>P</given-names></name> <name><surname>Zrinzo</surname> <given-names>L</given-names></name> <name><surname>Tripoliti</surname> <given-names>E</given-names></name> <name><surname>Aviles-Olmos</surname> <given-names>I</given-names></name> <name><surname>Jahanshahi</surname> <given-names>M</given-names></name></person-group>. <article-title>Gender differences in quality of life following subthalamic stimulation for Parkinson&#x2019;s disease</article-title>. <source>Acta Neurol Scand</source>. (<year>2013</year>) <volume>128</volume>:<fpage>281</fpage>&#x2013;<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.1111/ane.12127</pub-id>, PMID: <pub-id pub-id-type="pmid">23550919</pub-id></citation></ref>
<ref id="ref29"><label>29.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chiou</surname> <given-names>SM</given-names></name></person-group>. <article-title>Sex-related prognostic predictors for Parkinson disease undergoing subthalamic stimulation</article-title>. <source>World Neurosurg</source>. (<year>2015</year>) <volume>84</volume>:<fpage>906</fpage>&#x2013;<lpage>12</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.wneu.2015.05.023</pub-id></citation></ref>
<ref id="ref30"><label>30.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Accolla</surname> <given-names>E</given-names></name> <name><surname>Caputo</surname> <given-names>E</given-names></name> <name><surname>Cogiamanian</surname> <given-names>F</given-names></name> <name><surname>Tamma</surname> <given-names>F</given-names></name> <name><surname>Mrakic-Sposta</surname> <given-names>S</given-names></name></person-group>. <article-title>Gender differences in patients with Parkinson&#x2019;s disease treated with subthalamic deep brain stimulation</article-title>. <source>Mov Disord</source>. (<year>2007</year>) <volume>22</volume>:<fpage>1150</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1002/mds.21520</pub-id></citation></ref>
<ref id="ref31"><label>31.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Su</surname> <given-names>XL</given-names></name> <name><surname>Luo</surname> <given-names>XG</given-names></name> <name><surname>Lv</surname> <given-names>H</given-names></name> <name><surname>Wang</surname> <given-names>J</given-names></name> <name><surname>Ren</surname> <given-names>Y</given-names></name> <name><surname>He</surname> <given-names>ZY</given-names></name></person-group>. <article-title>Factors predicting the instant effect of motor function after subthalamic nucleus deep brain stimulation in Parkinson&#x2019;s disease</article-title>. <source>Transl Neurodegener</source>. (<year>2017</year>) <volume>6</volume>:<fpage>14</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s40035-017-0084-6</pub-id>, PMID: <pub-id pub-id-type="pmid">28580139</pub-id></citation></ref>
<ref id="ref32"><label>32.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname> <given-names>TS</given-names></name> <name><surname>Chen</surname> <given-names>YC</given-names></name> <name><surname>Liu</surname> <given-names>DF</given-names></name> <name><surname>Ma</surname> <given-names>RY</given-names></name> <name><surname>Zhang</surname> <given-names>X</given-names></name></person-group>. <article-title>Sex modulates the outcome of subthalamic nucleus deep brain stimulation in patients with Parkinson&#x2019;s disease</article-title>. <source>Neural Regen Res</source>. (<year>2023</year>) <volume>18</volume>:<fpage>901</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.4103/1673-5374.353506</pub-id>, PMID: <pub-id pub-id-type="pmid">36204861</pub-id></citation></ref>
<ref id="ref33"><label>33.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Romito</surname> <given-names>LM</given-names></name> <name><surname>Contarino</surname> <given-names>FM</given-names></name> <name><surname>Albanese</surname> <given-names>A</given-names></name></person-group>. <article-title>Transient gender-related effects in Parkinson&#x2019;s disease patients with subthalamic stimulation</article-title>. <source>J Neurol</source>. (<year>2010</year>) <volume>257</volume>:<fpage>603</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00415-009-5381-2</pub-id></citation></ref>
<ref id="ref34"><label>34.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andreasi</surname> <given-names>NG</given-names></name> <name><surname>Romito</surname> <given-names>LM</given-names></name> <name><surname>Telese</surname> <given-names>R</given-names></name> <name><surname>Cilia</surname> <given-names>R</given-names></name> <name><surname>Elia</surname> <given-names>AE</given-names></name></person-group>. <article-title>Short- and long-term motor outcome of Stn-Dbs in Parkinson&#x2019;s disease: focus on sex differences</article-title>. <source>Neurol Sci</source>. (<year>2022</year>) <volume>43</volume>:<fpage>1769</fpage>&#x2013;<lpage>81</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10072-021-05564-w</pub-id></citation></ref>
<ref id="ref35"><label>35.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roediger</surname> <given-names>J</given-names></name> <name><surname>Artusi</surname> <given-names>CA</given-names></name> <name><surname>Romagnolo</surname> <given-names>A</given-names></name> <name><surname>Boyne</surname> <given-names>P</given-names></name> <name><surname>Zibetti</surname> <given-names>M</given-names></name> <name><surname>Lopiano</surname> <given-names>L</given-names></name></person-group>. <article-title>Effect of subthalamic deep brain stimulation on posture in Parkinson&#x2019;s disease: a blind computerized analysis</article-title>. <source>Parkinsonism Relat Disord</source>. (<year>2019</year>) <volume>62</volume>:<fpage>122</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.parkreldis.2019.01.003</pub-id>, PMID: <pub-id pub-id-type="pmid">30638820</pub-id></citation></ref>
<ref id="ref36"><label>36.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Erdogan</surname> <given-names>S</given-names></name> <name><surname>Savas</surname> <given-names>A</given-names></name> <name><surname>Aydin</surname> <given-names>N</given-names></name> <name><surname>Akbostanci</surname> <given-names>MC</given-names></name></person-group>. <article-title>Predictive factors for favorable outcome from subthalamic nucleus deep brain stimulation in Parkinsonaeuros disease</article-title>. <source>Turk Neurosurg</source>. (<year>2020</year>) <volume>30</volume>:<fpage>43</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.5137/1019-5149.JTN.25028-18.3</pub-id></citation></ref>
<ref id="ref37"><label>37.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khazen</surname> <given-names>O</given-names></name> <name><surname>DiMarzio</surname> <given-names>M</given-names></name> <name><surname>Platanitis</surname> <given-names>K</given-names></name> <name><surname>Grimaudo</surname> <given-names>HC</given-names></name> <name><surname>Hancu</surname> <given-names>M</given-names></name> <name><surname>Shao</surname> <given-names>MM</given-names></name></person-group>. <article-title>Sex-specific effects of subthalamic nucleus stimulation on pain in Parkinson&#x2019;s disease</article-title>. <source>J Neurosurg</source>. (<year>2020</year>) <volume>1126</volume>:<fpage>1</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.3171/2020.6.JNS201126</pub-id>, PMID: <pub-id pub-id-type="pmid">33036000</pub-id></citation></ref>
<ref id="ref38"><label>38.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Castelli</surname> <given-names>L</given-names></name> <name><surname>Perozzo</surname> <given-names>P</given-names></name> <name><surname>Zibetti</surname> <given-names>M</given-names></name> <name><surname>Crivelli</surname> <given-names>B</given-names></name> <name><surname>Morabito</surname> <given-names>U</given-names></name> <name><surname>Lanotte</surname> <given-names>M</given-names></name></person-group>. <article-title>Chronic deep brain stimulation of the subthalamic nucleus for Parkinson&#x2019;s disease: effects on cognition, mood, anxiety and personality traits</article-title>. <source>Eur Neurol</source>. (<year>2006</year>) <volume>55</volume>:<fpage>136</fpage>&#x2013;<lpage>44</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000093213</pub-id></citation></ref>
<ref id="ref39"><label>39.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parsons</surname> <given-names>TD</given-names></name> <name><surname>Rogers</surname> <given-names>SA</given-names></name> <name><surname>Braaten</surname> <given-names>AJ</given-names></name> <name><surname>Woods</surname> <given-names>SP</given-names></name> <name><surname>Troster</surname> <given-names>AI</given-names></name></person-group>. <article-title>Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson&#x2019;s disease: a meta-analysis</article-title>. <source>Lancet Neurol</source>. (<year>2006</year>) <volume>5</volume>:<fpage>578</fpage>&#x2013;<lpage>88</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S1474-4422(06)70475-6</pub-id></citation></ref>
<ref id="ref40"><label>40.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bove</surname> <given-names>F</given-names></name> <name><surname>Fraix</surname> <given-names>V</given-names></name> <name><surname>Cavallieri</surname> <given-names>F</given-names></name> <name><surname>Schmitt</surname> <given-names>E</given-names></name> <name><surname>Lhommee</surname> <given-names>E</given-names></name> <name><surname>Bichon</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>Dementia and subthalamic deep brain stimulation in Parkinson disease: a long-term overview</article-title>. <source>Neurology</source>. (<year>2020</year>) <volume>95</volume>:<fpage>e384</fpage>&#x2013;<lpage>92</lpage>. doi: <pub-id pub-id-type="doi">10.1212/WNL.0000000000009822</pub-id>, PMID: <pub-id pub-id-type="pmid">32611633</pub-id></citation></ref>
<ref id="ref41"><label>41.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname> <given-names>T</given-names></name> <name><surname>Xie</surname> <given-names>H</given-names></name> <name><surname>Diao</surname> <given-names>Y</given-names></name> <name><surname>Fan</surname> <given-names>H</given-names></name> <name><surname>Wu</surname> <given-names>D</given-names></name> <name><surname>Gan</surname> <given-names>Y</given-names></name></person-group>. <article-title>Effects of subthalamic nucleus deep brain stimulation on depression in patients with Parkinson&#x2019;s disease</article-title>. <source>J Clin Med</source>. (<year>2022</year>) <volume>11</volume>:<fpage>95844</fpage>. doi: <pub-id pub-id-type="doi">10.3390/jcm11195844</pub-id>, PMID: <pub-id pub-id-type="pmid">36233710</pub-id></citation></ref>
<ref id="ref42"><label>42.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Castelli</surname> <given-names>L</given-names></name> <name><surname>Perozzo</surname> <given-names>P</given-names></name> <name><surname>Genesia</surname> <given-names>ML</given-names></name> <name><surname>Torre</surname> <given-names>E</given-names></name> <name><surname>Pesare</surname> <given-names>M</given-names></name></person-group>. <article-title>Sexual well being in parkinsonian patients after deep brain stimulation of the subthalamic nucleus</article-title>. <source>J Neurol Neurosurg Psychiatry</source>. (<year>2004</year>) <volume>75</volume>:<fpage>1260</fpage>&#x2013;<lpage>4</lpage>. doi: <pub-id pub-id-type="doi">10.1136/jnnp.2003.034579</pub-id></citation></ref>
<ref id="ref43"><label>43.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Merola</surname> <given-names>A</given-names></name> <name><surname>Romagnolo</surname> <given-names>A</given-names></name> <name><surname>Rizzi</surname> <given-names>L</given-names></name> <name><surname>Rizzone</surname> <given-names>MG</given-names></name> <name><surname>Zibetti</surname> <given-names>M</given-names></name> <name><surname>Lanotte</surname> <given-names>M</given-names></name></person-group>. <article-title>Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease</article-title>. <source>J Neurol</source>. (<year>2017</year>) <volume>264</volume>:<fpage>40</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00415-016-8314-x</pub-id></citation></ref>
<ref id="ref44"><label>44.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname> <given-names>RD</given-names></name> <name><surname>Wielenberg</surname> <given-names>B</given-names></name> <name><surname>Wojtecki</surname> <given-names>L</given-names></name> <name><surname>Elben</surname> <given-names>S</given-names></name> <name><surname>Campbell-Meiklejohn</surname> <given-names>D</given-names></name> <name><surname>Schnitzler</surname> <given-names>A</given-names></name></person-group>. <article-title>Deep brain stimulation of the subthalamic nucleus transiently enhances loss-chasing behaviour in patients with Parkinson&#x2019;s disease</article-title>. <source>Exp Neurol</source>. (<year>2011</year>) <volume>231</volume>:<fpage>181</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.expneurol.2011.06.007</pub-id></citation></ref>
<ref id="ref45"><label>45.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Georgiev</surname> <given-names>D</given-names></name> <name><surname>Mencinger</surname> <given-names>M</given-names></name> <name><surname>Rajnar</surname> <given-names>R</given-names></name> <name><surname>Music</surname> <given-names>P</given-names></name> <name><surname>Benedicic</surname> <given-names>M</given-names></name></person-group>. <article-title>Long-term effect of bilateral Stn-Dbs on non-motor symptoms in Parkinson&#x2019;s disease: a four-year observational, prospective study</article-title>. <source>Parkinsonism Relat Disord</source>. (<year>2021</year>) <volume>89</volume>:<fpage>13</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.parkreldis.2021.06.017</pub-id>, PMID: <pub-id pub-id-type="pmid">34216935</pub-id></citation></ref>
<ref id="ref46"><label>46.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>VS</given-names></name> <name><surname>Zhou</surname> <given-names>XP</given-names></name> <name><surname>Rahn</surname> <given-names>DA</given-names></name> <name><surname>Wang</surname> <given-names>EQ</given-names></name> <name><surname>Jiang</surname> <given-names>JJ</given-names></name></person-group>. <article-title>Perturbation and nonlinear dynamic analysis of acoustic Phonatory signal in parkinsonian patients receiving deep brain stimulation</article-title>. <source>J Commun Disord</source>. (<year>2008</year>) <volume>41</volume>:<fpage>485</fpage>&#x2013;<lpage>500</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jcomdis.2008.02.001</pub-id>, PMID: <pub-id pub-id-type="pmid">18433765</pub-id></citation></ref>
<ref id="ref47"><label>47.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname> <given-names>Y</given-names></name> <name><surname>Tsuboi</surname> <given-names>T</given-names></name> <name><surname>Watanabe</surname> <given-names>H</given-names></name> <name><surname>Kajita</surname> <given-names>Y</given-names></name> <name><surname>Fujimoto</surname> <given-names>Y</given-names></name> <name><surname>Ohdake</surname> <given-names>R</given-names></name></person-group>. <article-title>Voice features of Parkinson&#x2019;s disease patients with subthalamic nucleus deep brain stimulation</article-title>. <source>J Neurol</source>. (<year>2015</year>) <volume>262</volume>:<fpage>1173</fpage>&#x2013;<lpage>81</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00415-015-7681-z</pub-id></citation></ref>
<ref id="ref48"><label>48.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sarac</surname> <given-names>ET</given-names></name> <name><surname>Yilmaz</surname> <given-names>A</given-names></name> <name><surname>Aydinli</surname> <given-names>FE</given-names></name> <name><surname>Yildizgoren</surname> <given-names>MT</given-names></name> <name><surname>Okuyucu</surname> <given-names>EE</given-names></name></person-group>. <article-title>Investigating the effects of subthalamic nucleus-deep brain stimulation on the voice quality</article-title>. <source>Somatosens Mot Res</source>. (<year>2020</year>) <volume>37</volume>:<fpage>157</fpage>&#x2013;<lpage>64</lpage>. doi: <pub-id pub-id-type="doi">10.1080/08990220.2020.1761317</pub-id></citation></ref>
<ref id="ref49"><label>49.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname> <given-names>Y</given-names></name> <name><surname>Zhang</surname> <given-names>Y</given-names></name> <name><surname>Zheng</surname> <given-names>Z</given-names></name> <name><surname>Liu</surname> <given-names>A</given-names></name> <name><surname>Wang</surname> <given-names>X</given-names></name> <name><surname>Zhuang</surname> <given-names>P</given-names></name></person-group>. <article-title>Changes in speech characters of patients with Parkinson&#x2019;s disease after bilateral subthalamic nucleus stimulation</article-title>. <source>J Voice</source>. (<year>2011</year>) <volume>25</volume>:<fpage>751</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jvoice.2010.08.002</pub-id>, PMID: <pub-id pub-id-type="pmid">21227642</pub-id></citation></ref>
<ref id="ref50"><label>50.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>EM</given-names></name> <name><surname>Kurundkar</surname> <given-names>A</given-names></name> <name><surname>Cutter</surname> <given-names>GR</given-names></name> <name><surname>Huang</surname> <given-names>H</given-names></name> <name><surname>Guthrie</surname> <given-names>BL</given-names></name></person-group>. <article-title>Comparison of weight changes following unilateral and staged bilateral Stn Dbs for advanced Pd</article-title>. <source>Brain Behav</source>. (<year>2011</year>) <volume>1</volume>:<fpage>12</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1002/brb3.9</pub-id>, PMID: <pub-id pub-id-type="pmid">22398977</pub-id></citation></ref>
<ref id="ref51"><label>51.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bannier</surname> <given-names>S</given-names></name> <name><surname>Montaurier</surname> <given-names>C</given-names></name> <name><surname>Derost</surname> <given-names>PP</given-names></name> <name><surname>Ulla</surname> <given-names>M</given-names></name> <name><surname>Lemaire</surname> <given-names>JJ</given-names></name></person-group>. <article-title>Overweight after deep brain stimulation of the subthalamic nucleus in Parkinson disease: long term follow-up</article-title>. <source>J Neurol Neurosurg Psychiatry</source>. (<year>2009</year>) <volume>80</volume>:<fpage>484</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1136/jnnp.2008.158576</pub-id></citation></ref>
<ref id="ref52"><label>52.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Montaurier</surname> <given-names>C</given-names></name> <name><surname>Morio</surname> <given-names>B</given-names></name> <name><surname>Bannier</surname> <given-names>S</given-names></name> <name><surname>Derost</surname> <given-names>P</given-names></name> <name><surname>Arnaud</surname> <given-names>P</given-names></name> <name><surname>Brandolini-Bunlon</surname> <given-names>M</given-names></name></person-group>. <article-title>Mechanisms of body weight gain in patients with Parkinson&#x2019;s disease after subthalamic stimulation</article-title>. <source>Brain</source>. (<year>2007</year>) <volume>130</volume>:<fpage>1808</fpage>&#x2013;<lpage>18</lpage>. doi: <pub-id pub-id-type="doi">10.1093/brain/awm113</pub-id></citation></ref>
<ref id="ref53"><label>53.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Foubert-Samier</surname> <given-names>A</given-names></name> <name><surname>Maurice</surname> <given-names>S</given-names></name> <name><surname>Hivert</surname> <given-names>S</given-names></name> <name><surname>Guelh</surname> <given-names>D</given-names></name> <name><surname>Rigalleau</surname> <given-names>V</given-names></name></person-group>. <article-title>A long-term follow-up of weight changes in subthalamic nucleus stimulated Parkinson&#x2019;s disease patients</article-title>. <source>Rev Neurol (Paris)</source>. (<year>2012</year>) <volume>168</volume>:<fpage>173</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neurol.2011.04.006</pub-id></citation></ref>
<ref id="ref54"><label>54.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pedro</surname> <given-names>T</given-names></name> <name><surname>Sousa</surname> <given-names>M</given-names></name> <name><surname>Rito</surname> <given-names>M</given-names></name> <name><surname>Pereira</surname> <given-names>R</given-names></name> <name><surname>Januario</surname> <given-names>C</given-names></name> <name><surname>Moreira</surname> <given-names>F</given-names></name></person-group>. <article-title>The impact of deep brain stimulation on the sexual function of patients with Parkinson&#x2019;s disease</article-title>. <source>Neurologist</source>. (<year>2020</year>) <volume>25</volume>:<fpage>55</fpage>&#x2013;<lpage>61</lpage>. doi: <pub-id pub-id-type="doi">10.1097/NRL.0000000000000272</pub-id>, PMID: <pub-id pub-id-type="pmid">32358462</pub-id></citation></ref>
<ref id="ref55"><label>55.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rust</surname> <given-names>J</given-names></name> <name><surname>Golombok</surname> <given-names>S</given-names></name></person-group>. <article-title>The Golombok-Rust inventory of sexual satisfaction (Griss)</article-title>. <source>Br J Clin Psychol</source>. (<year>1985</year>) <volume>24</volume>:<fpage>63</fpage>&#x2013;<lpage>4</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.2044-8260.1985.tb01314.x</pub-id></citation></ref>
<ref id="ref56"><label>56.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Witte</surname> <given-names>LP</given-names></name> <name><surname>Odekerken</surname> <given-names>VJJ</given-names></name> <name><surname>Boel</surname> <given-names>JA</given-names></name> <name><surname>Schuurman</surname> <given-names>PR</given-names></name> <name><surname>Gerbrandy-Schreuders</surname> <given-names>LC</given-names></name> <name><surname>de Bie</surname> <given-names>RMA</given-names></name></person-group>. <article-title>Does deep brain stimulation improve lower urinary tract symptoms in Parkinson&#x2019;s disease?</article-title> <source>Neurourol Urodyn</source>. (<year>2018</year>) <volume>37</volume>:<fpage>354</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1002/nau.23301</pub-id></citation></ref>
<ref id="ref57"><label>57.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zong</surname> <given-names>H</given-names></name> <name><surname>Meng</surname> <given-names>F</given-names></name> <name><surname>Zhang</surname> <given-names>Y</given-names></name> <name><surname>Wei</surname> <given-names>G</given-names></name> <name><surname>Zhao</surname> <given-names>H</given-names></name></person-group>. <article-title>Clinical study of the effects of deep brain stimulation on urinary dysfunctions in patients with Parkinson&#x2019;s disease</article-title>. <source>Clin Interv Aging</source>. (<year>2019</year>) <volume>14</volume>:<fpage>1159</fpage>&#x2013;<lpage>66</lpage>. doi: <pub-id pub-id-type="doi">10.2147/CIA.S204368</pub-id>, PMID: <pub-id pub-id-type="pmid">31417246</pub-id></citation></ref>
<ref id="ref58"><label>58.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jenkinson</surname> <given-names>C</given-names></name> <name><surname>Fitzpatrick</surname> <given-names>R</given-names></name> <name><surname>Peto</surname> <given-names>V</given-names></name> <name><surname>Greenhall</surname> <given-names>R</given-names></name> <name><surname>Hyman</surname> <given-names>N</given-names></name></person-group>. <article-title>The Parkinson&#x2019;s disease questionnaire (pdq-39): development and validation of a Parkinson&#x2019;s disease summary index score</article-title>. <source>Age Ageing</source>. (<year>1997</year>) <volume>26</volume>:<fpage>353</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1093/ageing/26.5.353</pub-id></citation></ref>
<ref id="ref59"><label>59.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jenkinson</surname> <given-names>C</given-names></name> <name><surname>Fitzpatrick</surname> <given-names>R</given-names></name> <name><surname>Peto</surname> <given-names>V</given-names></name> <name><surname>Greenhall</surname> <given-names>R</given-names></name> <name><surname>Hyman</surname> <given-names>N</given-names></name></person-group>. <article-title>The pdq-8: development and validation of a short-form Parkinson&#x2019;s disease questionnaire</article-title>. <source>Psychol Health</source>. (<year>1997</year>) <volume>12</volume>:<fpage>805</fpage>&#x2013;<lpage>14</lpage>. doi: <pub-id pub-id-type="doi">10.1080/08870449708406741</pub-id></citation></ref>
<ref id="ref60"><label>60.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brazier</surname> <given-names>JE</given-names></name> <name><surname>Harper</surname> <given-names>R</given-names></name> <name><surname>Jones</surname> <given-names>NM</given-names></name> <name><surname>O&#x2019;Cathain</surname> <given-names>A</given-names></name> <name><surname>Thomas</surname> <given-names>KJ</given-names></name> <name><surname>Usherwood</surname> <given-names>T</given-names></name> <etal/></person-group>. <article-title>Validating the sf-36 health survey questionnaire: new outcome measure for primary care</article-title>. <source>BMJ</source>. (<year>1992</year>) <volume>305</volume>:<fpage>160</fpage>&#x2013;<lpage>4</lpage>. doi: <pub-id pub-id-type="doi">10.1136/bmj.305.6846.160</pub-id>, PMID: <pub-id pub-id-type="pmid">1285753</pub-id></citation></ref>
<ref id="ref61"><label>61.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>R</given-names></name> <name><surname>Yoo</surname> <given-names>D</given-names></name> <name><surname>Jung</surname> <given-names>YJ</given-names></name> <name><surname>Lee</surname> <given-names>WW</given-names></name> <name><surname>Ehm</surname> <given-names>G</given-names></name> <name><surname>Yun</surname> <given-names>JY</given-names></name></person-group>. <article-title>Determinants of functional Independence or its loss following subthalamic nucleus stimulation in Parkinson&#x2019;s disease</article-title>. <source>Stereotact Funct Neurosurg</source>. (<year>2019</year>) <volume>97</volume>:<fpage>106</fpage>&#x2013;<lpage>12</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000500277</pub-id></citation></ref>
<ref id="ref62"><label>62.</label> <citation citation-type="book"><person-group person-group-type="author"><name><surname>Schwab</surname> <given-names>RS</given-names></name> <name><surname>England</surname> <given-names>AC</given-names></name></person-group>. <article-title>Projection technique for evaluating surgery in Parkinson&#x2019;s disease</article-title>. In: FJ Gillingham, IML Donaldson, editors. <source>Third symposium on Parkinson&#x2019;s disease</source>. Edingurgh, Livingstone (<year>1969</year>), p. <fpage>152</fpage>&#x2013;<lpage>57</lpage>.</citation></ref>
<ref id="ref63"><label>63.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hariz</surname> <given-names>GM</given-names></name> <name><surname>Nakajima</surname> <given-names>T</given-names></name> <name><surname>Limousin</surname> <given-names>P</given-names></name> <name><surname>Foltynie</surname> <given-names>T</given-names></name> <name><surname>Zrinzo</surname> <given-names>L</given-names></name></person-group>. <article-title>Gender distribution of patients with Parkinson&#x2019;s disease treated with subthalamic deep brain stimulation; a review of the 2000&#x2013;2009 literature</article-title>. <source>Parkinsonism Relat Disord</source>. (<year>2011</year>) <volume>17</volume>:<fpage>146</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.parkreldis.2010.12.002</pub-id></citation></ref>
<ref id="ref64"><label>64.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname> <given-names>R</given-names></name> <name><surname>Kompoliti</surname> <given-names>K</given-names></name></person-group>. <article-title>Sex and gender differences in Parkinson&#x2019;s disease</article-title>. <source>Neurol Clin</source>. (<year>2023</year>) <volume>41</volume>:<fpage>371</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ncl.2022.12.001</pub-id></citation></ref>
<ref id="ref65"><label>65.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cerri</surname> <given-names>S</given-names></name> <name><surname>Mus</surname> <given-names>L</given-names></name> <name><surname>Blandini</surname> <given-names>F</given-names></name></person-group>. <article-title>Parkinson&#x2019;s disease in women and men: What&#x2019;s the difference?</article-title> <source>J Parkinsons Dis</source>. (<year>2019</year>) <volume>9</volume>:<fpage>501</fpage>&#x2013;<lpage>15</lpage>. doi: <pub-id pub-id-type="doi">10.3233/JPD-191683</pub-id>, PMID: <pub-id pub-id-type="pmid">31282427</pub-id></citation></ref>
<ref id="ref66"><label>66.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Voon</surname> <given-names>V</given-names></name> <name><surname>Napier</surname> <given-names>TC</given-names></name> <name><surname>Frank</surname> <given-names>MJ</given-names></name> <name><surname>Sgambato-Faure</surname> <given-names>V</given-names></name> <name><surname>Grace</surname> <given-names>AA</given-names></name></person-group>. <article-title>Impulse control disorders and levodopa-induced Dyskinesias in Parkinson&#x2019;s disease: an update</article-title>. <source>Lancet Neurol</source>. (<year>2017</year>) <volume>16</volume>:<fpage>238</fpage>&#x2013;<lpage>50</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s1474-4422(17)30004-2</pub-id>, PMID: <pub-id pub-id-type="pmid">28229895</pub-id></citation></ref>
<ref id="ref67"><label>67.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brezovar</surname> <given-names>S</given-names></name> <name><surname>Pazek</surname> <given-names>L</given-names></name> <name><surname>Kavcic</surname> <given-names>M</given-names></name> <name><surname>Georgiev</surname> <given-names>D</given-names></name> <name><surname>Trost</surname> <given-names>M</given-names></name> <name><surname>Flisar</surname> <given-names>D</given-names></name></person-group>. <article-title>Personality changes after subthalamic nucleus stimulation in Parkinson&#x2019;s disease</article-title>. <source>J Parkinsons Dis</source>. (<year>2022</year>) <volume>12</volume>:<fpage>1231</fpage>&#x2013;<lpage>40</lpage>. doi: <pub-id pub-id-type="doi">10.3233/JPD-212879</pub-id>, PMID: <pub-id pub-id-type="pmid">35342047</pub-id></citation></ref>
<ref id="ref68"><label>68.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baudouin</surname> <given-names>R</given-names></name> <name><surname>Lechien</surname> <given-names>JR</given-names></name> <name><surname>Carpentier</surname> <given-names>L</given-names></name> <name><surname>Gurruchaga</surname> <given-names>JM</given-names></name> <name><surname>Lisan</surname> <given-names>Q</given-names></name></person-group>. <article-title>Deep brain stimulation impact on voice and speech quality in Parkinson&#x2019;s disease: a systematic review</article-title>. <source>Otolaryngol Head Neck Surg</source>. (<year>2023</year>) <volume>168</volume>:<fpage>307</fpage>&#x2013;<lpage>18</lpage>. doi: <pub-id pub-id-type="doi">10.1177/01945998221120189</pub-id></citation></ref>
<ref id="ref69"><label>69.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname> <given-names>P</given-names></name> <name><surname>Covassin</surname> <given-names>N</given-names></name> <name><surname>Marlatt</surname> <given-names>K</given-names></name> <name><surname>Gadde</surname> <given-names>KM</given-names></name> <name><surname>Heymsfield</surname> <given-names>SB</given-names></name></person-group>. <article-title>Obesity, body composition, and sex hormones: implications for cardiovascular risk</article-title>. <source>Compr Physiol</source>. (<year>2021</year>) <volume>12</volume>:<fpage>2949</fpage>&#x2013;<lpage>93</lpage>. doi: <pub-id pub-id-type="doi">10.1002/cphy.c210014</pub-id>, PMID: <pub-id pub-id-type="pmid">34964120</pub-id></citation></ref>
<ref id="ref70"><label>70.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meoni</surname> <given-names>S</given-names></name> <name><surname>Macerollo</surname> <given-names>A</given-names></name> <name><surname>Moro</surname> <given-names>E</given-names></name></person-group>. <article-title>Sex differences in movement disorders</article-title>. <source>Nat Rev Neurol</source>. (<year>2020</year>) <volume>16</volume>:<fpage>84</fpage>&#x2013;<lpage>96</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41582-019-0294-x</pub-id></citation></ref>
<ref id="ref71"><label>71.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pallayova</surname> <given-names>M</given-names></name> <name><surname>Brandeburova</surname> <given-names>A</given-names></name> <name><surname>Tokarova</surname> <given-names>D</given-names></name></person-group>. <article-title>Update on sexual dimorphism in brain structure-function interrelationships: a literature review</article-title>. <source>Appl Psychophysiol Biofeedback</source>. (<year>2019</year>) <volume>44</volume>:<fpage>271</fpage>&#x2013;<lpage>84</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10484-019-09443-1</pub-id></citation></ref>
<ref id="ref72"><label>72.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ruigrok</surname> <given-names>AN</given-names></name> <name><surname>Salimi-Khorshidi</surname> <given-names>G</given-names></name> <name><surname>Lai</surname> <given-names>MC</given-names></name> <name><surname>Baron-Cohen</surname> <given-names>S</given-names></name> <name><surname>Lombardo</surname> <given-names>MV</given-names></name></person-group>. <article-title>A meta-analysis of sex differences in human brain structure</article-title>. <source>Neurosci Biobehav Rev</source>. (<year>2014</year>) <volume>39</volume>:<fpage>34</fpage>&#x2013;<lpage>50</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neubiorev.2013.12.004</pub-id></citation></ref>
<ref id="ref73"><label>73.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Whitwell</surname> <given-names>JL</given-names></name> <name><surname>Josephs</surname> <given-names>KA</given-names></name></person-group>. <article-title>Voxel-based morphometry and its application to movement disorders</article-title>. <source>Parkinsonism Relat Disord</source>. (<year>2007</year>) <volume>13</volume>:<fpage>S406</fpage>&#x2013;<lpage>16</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S1353-8020(08)70039-7</pub-id>, PMID: <pub-id pub-id-type="pmid">18267273</pub-id></citation></ref>
<ref id="ref74"><label>74.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname> <given-names>MT</given-names></name> <name><surname>White</surname> <given-names>SJ</given-names></name> <name><surname>Chaudhuri</surname> <given-names>KR</given-names></name> <name><surname>Morris</surname> <given-names>RG</given-names></name> <name><surname>Bydder</surname> <given-names>GM</given-names></name></person-group>. <article-title>Correlating rates of cerebral atrophy in Parkinson&#x2019;s disease with measures of cognitive decline</article-title>. <source>J Neural Transm (Vienna)</source>. (<year>2001</year>) <volume>108</volume>:<fpage>571</fpage>&#x2013;<lpage>80</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s007020170057</pub-id></citation></ref>
<ref id="ref75"><label>75.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yadav</surname> <given-names>SK</given-names></name> <name><surname>Kathiresan</surname> <given-names>N</given-names></name> <name><surname>Mohan</surname> <given-names>S</given-names></name> <name><surname>Vasileiou</surname> <given-names>G</given-names></name> <name><surname>Singh</surname> <given-names>A</given-names></name> <name><surname>Kaura</surname> <given-names>D</given-names></name></person-group>. <article-title>Gender-based analysis of cortical thickness and structural connectivity in Parkinson&#x2019;s disease</article-title>. <source>J Neurol</source>. (<year>2016</year>) <volume>263</volume>:<fpage>2308</fpage>&#x2013;<lpage>18</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00415-016-8265-2</pub-id>, PMID: <pub-id pub-id-type="pmid">27544505</pub-id></citation></ref>
<ref id="ref76"><label>76.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brenner</surname> <given-names>RP</given-names></name> <name><surname>Ulrich</surname> <given-names>RF</given-names></name> <name><surname>Reynolds</surname> <given-names>CF</given-names></name></person-group>. <article-title>EEG spectral findings in healthy, elderly men and women-sex differences</article-title>. <source>Electroencephalogr Clin Neurophysiol</source>. (<year>1995</year>) <volume>94</volume>:<fpage>1</fpage>&#x2013;<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0013-4694(94)00234-c</pub-id></citation></ref>
<ref id="ref77"><label>77.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nikulin</surname> <given-names>VV</given-names></name> <name><surname>Brismar</surname> <given-names>T</given-names></name></person-group>. <article-title>Phase synchronization between alpha and Beta oscillations in the human electroencephalogram</article-title>. <source>Neuroscience</source>. (<year>2006</year>) <volume>137</volume>:<fpage>647</fpage>&#x2013;<lpage>57</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuroscience.2005.10.031</pub-id></citation></ref>
<ref id="ref78"><label>78.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marceglia</surname> <given-names>S</given-names></name> <name><surname>Mrakic-Sposta</surname> <given-names>S</given-names></name> <name><surname>Foffani</surname> <given-names>G</given-names></name> <name><surname>Cogiamanian</surname> <given-names>F</given-names></name> <name><surname>Caputo</surname> <given-names>E</given-names></name></person-group>. <article-title>Gender-related differences in the human subthalamic area: a local field potential study</article-title>. <source>Eur J Neurosci</source>. (<year>2006</year>) <volume>24</volume>:<fpage>3213</fpage>&#x2013;<lpage>22</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1460-9568.2006.05208.x</pub-id>, PMID: <pub-id pub-id-type="pmid">17156382</pub-id></citation></ref>
<ref id="ref79"><label>79.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname> <given-names>KM</given-names></name> <name><surname>Dahodwala</surname> <given-names>N</given-names></name></person-group>. <article-title>Sex differences in Parkinson&#x2019;s disease and other movement disorders</article-title>. <source>Exp Neurol</source>. (<year>2014</year>) <volume>259</volume>:<fpage>44</fpage>&#x2013;<lpage>56</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.expneurol.2014.03.010</pub-id></citation></ref>
<ref id="ref80"><label>80.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Loke</surname> <given-names>H</given-names></name> <name><surname>Harley</surname> <given-names>V</given-names></name> <name><surname>Lee</surname> <given-names>J</given-names></name></person-group>. <article-title>Biological factors underlying sex differences in neurological disorders</article-title>. <source>Int J Biochem Cell Biol</source>. (<year>2015</year>) <volume>65</volume>:<fpage>139</fpage>&#x2013;<lpage>50</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biocel.2015.05.024</pub-id></citation></ref>
<ref id="ref81"><label>81.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pinares-Garcia</surname> <given-names>P</given-names></name> <name><surname>Stratikopoulos</surname> <given-names>M</given-names></name> <name><surname>Zagato</surname> <given-names>A</given-names></name> <name><surname>Loke</surname> <given-names>H</given-names></name> <name><surname>Lee</surname> <given-names>J</given-names></name></person-group>. <article-title>Sex: a significant risk factor for neurodevelopmental and neurodegenerative disorders</article-title>. <source>Brain Sci</source>. (<year>2018</year>) <volume>8</volume>:<fpage>80154</fpage>. doi: <pub-id pub-id-type="doi">10.3390/brainsci8080154</pub-id></citation></ref>
<ref id="ref82"><label>82.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marrocco</surname> <given-names>J</given-names></name> <name><surname>McEwen</surname> <given-names>BS</given-names></name></person-group>. <article-title>Sex in the brain: hormones and sex differences</article-title>. <source>Dialogues Clin Neurosci</source>. (<year>2016</year>) <volume>18</volume>:<fpage>373</fpage>&#x2013;<lpage>83</lpage>. doi: <pub-id pub-id-type="doi">10.31887/DCNS.2016.18.4/jmarrocco</pub-id>, PMID: <pub-id pub-id-type="pmid">28179809</pub-id></citation></ref>
<ref id="ref83"><label>83.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname> <given-names>IN</given-names></name> <name><surname>Cronin-Golomb</surname> <given-names>A</given-names></name></person-group>. <article-title>Gender differences in Parkinson&#x2019;s disease: clinical characteristics and cognition</article-title>. <source>Mov Disord</source>. (<year>2010</year>) <volume>25</volume>:<fpage>2695</fpage>&#x2013;<lpage>703</lpage>. doi: <pub-id pub-id-type="doi">10.1002/mds.23388</pub-id>, PMID: <pub-id pub-id-type="pmid">20925068</pub-id></citation></ref>
<ref id="ref84"><label>84.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bao</surname> <given-names>AM</given-names></name> <name><surname>Swaab</surname> <given-names>DF</given-names></name></person-group>. <article-title>Sex differences in the brain, behavior, and neuropsychiatric disorders</article-title>. <source>Neuroscientist</source>. (<year>2010</year>) <volume>16</volume>:<fpage>550</fpage>&#x2013;<lpage>65</lpage>. doi: <pub-id pub-id-type="doi">10.1177/1073858410377005</pub-id></citation></ref>
<ref id="ref85"><label>85.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Riecher-Rossler</surname> <given-names>A</given-names></name></person-group>. <article-title>Prospects for the classification of mental disorders in women</article-title>. <source>Eur Psychiatry</source>. (<year>2010</year>) <volume>25</volume>:<fpage>189</fpage>&#x2013;<lpage>96</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.eurpsy.2009.03.002</pub-id></citation></ref>
<ref id="ref86"><label>86.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cerrato</surname> <given-names>J</given-names></name> <name><surname>Cifre</surname> <given-names>E</given-names></name></person-group>. <article-title>Gender inequality in household chores and work-family conflict</article-title>. <source>Front Psychol</source>. (<year>2018</year>) <volume>9</volume>:<fpage>1330</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpsyg.2018.01330</pub-id></citation></ref>
</ref-list>
</back>
</article>